image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
2ec57c5ecd732368d90ca605190925d8a0e64445abf6eaefcb7b46c662c7280b.png | complex | <table><tr><td>Clinicopathological features</td><td>n</td><td colspan="2"><i>BICD1</i> expression, n (%)</td><td rowspan="2"><i>P</i></td></tr><tr><td></td><td>523</td><td>Low, n=262 (50.1)</td><td>High, n=261 (49.9)</td></tr><tr><td>Age</td><td></td><td></td><td></td><td>0.089722</td></tr><tr><td> <65</td><td>347</... | <table><tr><td>Clinicopathological features</td><td>n</td><td>BICD1 expression, n (%)</td></tr><tr><td></td><td>523</td><td>Low, n=262 (50.1)</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td><65</td><td>347</td><td>183 (52.7)</td></tr><tr><td>≥65</td><td>176</td><td>79 (44.9)</td></tr><tr><td>Gender</td><td></td... | <table><tr><td>BICD1 expression, n (%)</td><td rowspan="2">P</td></tr><tr><td>High, n=261 (49.9)</td></tr><tr><td></td><td>0.089722</td></tr><tr><td>164 (47.3)</td><td></td></tr><tr><td>97 (55.1)</td><td></td></tr><tr><td></td><td>0.136863</td></tr><tr><td>94 (45.9)</td><td></td></tr><tr><td>167 (52.5)</td><td></td></t... |
72853a20eb42c67209a174e6710c97e145b90e8ef9cca213988a6cae32e52b53.png | simple | <table><tr><td>Variable</td><td>Opium addicted N=50</td><td>Non addicted N=50</td><td>P value</td></tr><tr><td>Age Mean±SD</td><td>36.00±6.54</td><td>35.38±6.7</td><td>0.64</td></tr><tr><td>BMI Mean±sD</td><td>21.96±3.46</td><td>24.27±3.85</td><td>0.002</td></tr><tr><td>Cigarrette smoking... | <table><tr><td>Variable</td><td>Opium addicted N=50</td><td>Non addicted N=50</td><td>P value</td></tr><tr><td>Age Mean±SD</td><td>36.00±6.54</td><td>35.38±6.7</td><td>0.64</td></tr></table> | <table><tr><td>Variable</td><td>Opium addicted N=50</td><td>Non addicted N=50</td><td>P value</td></tr><tr><td>BMI Mean±sD</td><td>21.96±3.46</td><td>24.27±3.85</td><td>0.002</td></tr><tr><td>Cigarrette smoking No. (%)</td><td>37 (77.1)</td><td>34 (61)</td><td>0.31</td></tr><tr><td>Vertebral BMD frequency (%)</td><td>... |
0db75bfcda2ad762c7e7738ed1efb5556b83d87bd046d6ba50dcd97a63959912.png | simple | <table><tr><td>National policies and guidelines</td></tr><tr><td>Recording and Reporting tools</td></tr><tr><td>Collaboration and communication between TB and HIV control programmes</td></tr><tr><td>Leadership and commitment</td></tr><tr><td>Target setting at all levels of the health care system</td></tr><tr><td>Human ... | <table><tr><td>National policies and guidelines</td></tr><tr><td>Recording and Reporting tools</td></tr><tr><td>Collaboration and communication between TB and HIV control programmes</td></tr></table> | <table><tr><td>National policies and guidelines</td></tr><tr><td>Leadership and commitment</td></tr><tr><td>Target setting at all levels of the health care system</td></tr><tr><td>Human resources: recruitment, training, support, task shifting</td></tr><tr><td>Financing</td></tr><tr><td>National Partnerships for results... |
c0c68027b707338e960213efd58f9a102a3953aaa0e616976b5298e668cf1cbe.png | complex | <table><tr><td>Gene</td><td>Primers</td></tr><tr><td rowspan="2">ABCG2</td><td>Primer1: 5′-TGGCTTAGACTCAAGCACAGC-3′</td></tr><tr><td>Primer2: 5′- TGGTCCCTGCTTAGACATCC-3′</td></tr><tr><td rowspan="2">MRP1</td><td>Primer1: 5′-TGTGGGAAAACACATCTTTGA-3′</td></tr><tr><td>Primer2: 5′-... | <table><tr><td>Gene</td><td>Primers</td></tr><tr><td rowspan="2">ABCG2</td><td>Primer1: 5′-TGGCTTAGACTCAAGCACAGC-3′</td></tr><tr><td>Primer2: 5′- TGGTCCCTGCTTAGACATCC-3′</td></tr><tr><td rowspan="2">MRP1</td><td>Primer1: 5′-TGTGGGAAAACACATCTTTGA-3′</td></tr><tr><td>Primer2: 5′-CTGTGCGTGACCAAGATCC-3′</td></tr><tr><td ro... | <table><tr><td>Gene</td><td>Primers</td></tr><tr><td rowspan="2">Oct-4</td><td>Primer1: 5′-GGAAGGTATTCAGCCAAACGACCA-3′</td></tr><tr><td>Primer2: 5′'-CTCACTCGGTTCTCGATACTGGTT-3′</td></tr><tr><td rowspan="2">Sox2</td><td>Primer1: 5′-TTCGATCCCAACTTTCCAT-3′</td></tr><tr><td>Primer2: 5′'-ACATGGATTCTCGGCAGAC-3′</td></tr><tr>... |
ac207fbd473ca55c8e20c3b1464bea4ec14c9df5824171be817c47ddbaff909c.png | simple | <table><tr><td>Age</td><td>Number of Pupils (%)</td></tr><tr><td>16–17</td><td>214 (24.2)</td></tr><tr><td>18–19</td><td>397 (44.9)</td></tr><tr><td>20–22</td><td>272 (30.8)</td></tr><tr><td>Total</td><td>883</td></tr></table> | <table><tr><td>Age</td></tr><tr><td>16–17</td></tr><tr><td>18–19</td></tr><tr><td>20–22</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Number of Pupils (%)</td></tr><tr><td>214 (24.2)</td></tr><tr><td>397 (44.9)</td></tr><tr><td>272 (30.8)</td></tr><tr><td>883</td></tr></table> |
623dbfe63a11383f16e216280260433c77fd614b691577e3d678cfcb58857de1.png | simple | <table><tr><td>Study</td><td>Running distance</td><td>Running period</td><td>OA induced</td><td>Method</td><td>Effect</td></tr><tr><td>Sekiya et al. [5] 2009</td><td>30 km</td><td>6 weeks</td><td>No</td><td></td><td>Harmful</td></tr><tr><td>Siebelt et al. [24] 2011</td><td>31.8 km</td><td>6 weeks</td><td>No</td><td></t... | <table><tr><td>Study</td><td>Running distance</td><td>Running period</td><td>OA induced</td><td>Method</td><td>Effect</td></tr><tr><td>Sekiya et al. [5] 2009</td><td>30 km</td><td>6 weeks</td><td>No</td><td></td><td>Harmful</td></tr><tr><td>Siebelt et al. [24] 2011</td><td>31.8 km</td><td>6 weeks</td><td>No</td><td></t... | <table><tr><td>Saito et al. 2015</td><td>15 km</td><td>3 weeks</td><td>Yes</td><td>MIA 0.1 mg injection</td><td>Harmful</td></tr><tr><td>Galois et al. [22] 2004</td><td>15 km</td><td>4 weeks</td><td>Yes</td><td>ACLT</td><td>Beneficial</td></tr><tr><td>Cifuentes et al. [23] 2010</td><td>15 km</td><td>8 weeks</td><td>Yes... |
f7badf89095a359bc54cd70cdeb628f2ee173a0aa3a8bfda8d6ac4c09f6aed89.png | simple | <table><tr><td></td><td>Baseline Value</td><td>Source(s)</td></tr><tr><td>Input variables</td><td></td><td></td></tr><tr><td> Chest pain is caused by ACS</td><td>0.1</td><td>[19-22]</td></tr><tr><td> GP Sensitivity with ECG</td><td>0.818</td><td>Unpublished data from [8,11-16]</td></tr><tr><td> GP Sensitivity without E... | <table><tr><td></td><td>Baseline Value</td><td>Source(s)</td></tr><tr><td>Input variables</td><td></td><td></td></tr><tr><td>Chest pain is caused by ACS</td><td>0.1</td><td>[19-22]</td></tr><tr><td>GP Sensitivity with ECG</td><td>0.818</td><td>Unpublished data from [8,11-16]</td></tr><tr><td>GP Sensitivity without ECG<... | <table><tr><td>Admission</td><td>157.55</td><td>[37]</td></tr><tr><td>Blood transfusion</td><td>107.67</td><td>[37]</td></tr><tr><td>Stroke</td><td>211.37</td><td>[37]</td></tr><tr><td>Annual secondary prevention</td><td>16.56</td><td>[37,38]</td></tr></table> |
0a3192fb9c38c35fd588c4ba7efa23b3a168f37454df7653e9425d69677847c1.png | simple | <table><tr><td>#</td><td>Author</td><td>Year</td><td>Compound</td><td>Strain</td><td>Dose</td><td>Rote</td><td>Test</td><td>(Model)</td></tr><tr><td>1</td><td>Nagase <i>et al</i>. </td><td>2002 </td><td>TAN-67 </td><td>SD </td><td>1-10 mg/kg </td><td>s.c. </td><td>FSS </td><td></td></tr><tr><td>2</td><td>Broom <i>et al... | <table><tr><td>#</td><td>Author</td><td>Year</td><td>Compound</td><td>Strain</td><td>Dose</td><td>Rote</td><td>Test</td><td>(Model)</td></tr></table> | <table><tr><td>1</td><td>Nagase et al.</td><td>2002</td><td>TAN-67</td><td>SD</td><td>1-10 mg/kg</td><td>s.c.</td><td>FSS</td><td></td></tr><tr><td>2</td><td>Broom et al.</td><td>2002</td><td>SNC80</td><td>SD</td><td>10-100 mg/kg</td><td>s.c.</td><td>FSS</td><td></td></tr><tr><td>3</td><td>Broom et al.</td><td>2002</td... |
dccc0ff396df7b6b7993a2c3254dd81306b8442c3dd00f48f118d0cbd3bd63d6.png | complex | <table><tr><td> </td><td colspan="5">Predictability of Spherical Equivalent*</td><td> </td></tr><tr><td> </td><td>undercorrection <1.0</td><td>1.0 to 0.51</td><td>±0.5</td><td>0.51 to 1.0</td><td>overcorrection >1.0</td><td>Total</td></tr><tr><td> </td><td colspan="5">WTR</td><td> </td></tr><tr><td>Number</t... | <table><tr><td></td><td colspan="5">Predictability of Spherical Equivalent*</td><td></td></tr></table> | <table><tr><td></td><td>undercorrection <1.0</td><td>1.0 to 0.51</td><td>±0.5</td><td>0.51 to 1.0</td><td>overcorrection >1.0</td><td>Total</td></tr><tr><td></td><td colspan="5">WTR</td><td></td></tr><tr><td>Number</td><td>1</td><td>9</td><td>34</td><td>6</td><td>0</td><td>50</td></tr><tr><td>%</td><td>2</td><td>18</td... |
1044620b1ad4c08b5638a7646d91c908871f8ed1ba85b9aa229b2d9927a297dd.png | complex | <table><tr><td rowspan="2">Y-Intercept (#/cm<sup>3</sup>)</td><td colspan="2">Weekday</td><td colspan="2">Weekend</td></tr><tr><td>Day</td><td>Night</td><td>Day</td><td>Night</td></tr><tr><td>Ultrafine </td><td>50 (5)</td><td>101 (8)</td><td>43 (11)</td><td>143 (7)</td></tr><tr><td>Fine </td><td>48 (2)</td><td>62 (2)</... | <table><tr><td rowspan="2">Y-Intercept (#/cm3)</td><td colspan="2">Weekday</td></tr><tr><td>Day</td><td>Night</td></tr><tr><td>Ultrafine</td><td>50 (5)</td><td>101 (8)</td></tr><tr><td>Fine</td><td>48 (2)</td><td>62 (2)</td></tr></table> | <table><tr><td colspan="2">Weekend</td></tr><tr><td>Day</td><td>Night</td></tr><tr><td>43 (11)</td><td>143 (7)</td></tr><tr><td>46 (5)</td><td>90 (3)</td></tr></table> |
2bb1698bae0b79c0cb1d22063d21bdcbf361bb08f33ea176af1bb4c2400a4f21.png | complex | <table><tr><td>QUICKI</td><td></td><td colspan="2">tertile 1</td><td colspan="2">tertile 2</td><td colspan="2">tertile 3</td></tr><tr><td></td><td>Model</td><td># events</td><td>HR (95%CI)</td><td># events</td><td>HR (95%CI)</td><td># events</td><td>HR (95%CI)</td></tr><tr><td>All vascular events</td><td>1</td><td>48</... | <table><tr><td>QUICKI</td><td></td><td colspan="2">tertile 1</td><td colspan="2">tertile 2</td><td colspan="2">tertile 3</td></tr><tr><td></td><td>Model</td><td># events</td><td>HR (95%CI)</td><td># events</td><td>HR (95%CI)</td><td># events</td><td>HR (95%CI)</td></tr></table> | <table><tr><td>All vascular events</td><td>1</td><td>48</td><td>1.70 (1.05-2.74)</td><td>52</td><td>1.86 (1.16-2.98)</td><td>26</td><td>1 (reference)</td></tr><tr><td></td><td>2</td><td></td><td>1.78 (1.10-2.89)</td><td></td><td>1.92 (1.20-3.08)</td><td></td><td>1 (reference)</td></tr><tr><td></td><td>3</td><td></td><t... |
0ecf6f7e1bda0771caa2c96807664bbba53e20cd46c6776ac41fd34f23fd9696.png | complex | <table><tr><td></td><td colspan="2">TBIC practice</td><td></td><td></td></tr><tr><td>Variables</td><td>Proper</td><td>Improper</td><td>COR 95 % CI</td><td>AOR 95 % CI</td></tr><tr><td colspan="5">Site of health facility</td></tr><tr><td> Urban</td><td>82</td><td>139</td><td>0.94 (0.67,1.32)</td><td></td></tr><tr><td> R... | <table><tr><td></td><td colspan="2">TBIC practice</td><td></td><td></td></tr><tr><td>Variables</td><td>Proper</td><td>Improper</td><td>COR 95 % CI</td><td>AOR 95 % CI</td></tr><tr><td colspan="5">Site of health facility</td></tr><tr><td>Urban</td><td>82</td><td>139</td><td>0.94 (0.67,1.32)</td><td></td></tr><tr><td>Rur... | <table><tr><td>Yes</td><td>22</td><td>6</td><td>.26,4.47)</td><td>.04)</td></tr><tr><td>No</td><td>118</td><td>295</td><td>1</td><td>1</td></tr><tr><td colspan="5">Knowledge presence of TBIC plan</td></tr><tr><td>Yes</td><td>221</td><td>239</td><td>7.40 (4.44,12.32)</td><td>4.25 (2.46,7.35)*</td></tr><tr><td>No</td><td... |
4e8d5398eb3511e739d10625578b01be74ce4929e02a19ef0f20554c510eb9b2.png | simple | <table><tr><td></td><td>Haddadi <i>et al.</i></td><td>Huang <i>et al.</i></td><td>Lu &Zoubir</td><td>Ours</td></tr><tr><td><i>E</i>(<i>l<sub>q</sub></i>)</td><td>Lawley</td><td>Lawley</td><td>Lawley</td><td>Lawley</td></tr><tr><td><i>Var</i>(<i>l<sub>q</sub></i>)</td><td>Multivariate Statistics</td><td>Random Matri... | <table><tr><td></td><td>Haddadi et al.</td><td>Huang et al.</td><td>Lu &Zoubir</td><td>Ours</td></tr></table> | <table><tr><td>E(lq)</td><td>Lawley</td><td>Lawley</td><td>Lawley</td><td>Lawley</td></tr><tr><td>Var(lq)</td><td>Multivariate Statistics</td><td>Random Matrix</td><td>Random Matrix</td><td>Lawley</td></tr><tr><td>E(Aq)</td><td>Lawley</td><td>Lawley</td><td>Lawley</td><td>Lawley</td></tr><tr><td>Var(Aq)</td><td>- *</td... |
acb61adaffa4adf606c1a173e586e8f98fedba6b638f965a14bd915e11d5d836.png | simple | <table><tr><td>Disability</td><td>No or Other Resistance (n = 220)</td><td>INH Resistant (n = 86)</td><td>RIF Resistant or MDR (n = 16)</td><td>Cumulative Odds Ratio<sup>a</sup>(95% CI)</td><td><i>P</i> Value</td></tr><tr><td>Good</td><td>91 (41.4)</td><td>31 (36.0)</td><td>2 (12.5)</td><td>INH: 1.44</td><td></td></tr>... | <table><tr><td>Disability</td><td>No or Other Resistance (n = 220)</td><td>INH Resistant (n = 86)</td><td>RIF Resistant or MDR (n = 16)</td><td>Cumulative Odds Ratioa(95% CI)</td><td>P Value</td></tr><tr><td></td><td></td><td>31 </td><td>2 </td><td>IN</td><td></td></tr></table> | <table><tr><td>Disability</td><td>No or Other Resistance (n = 220)</td><td>INH Resistant (n = 86)</td><td>RIF Resistant or MDR (n = 16)</td><td>Cumulative Odds Ratioa(95% CI)</td><td>P Value</td></tr><tr><td>Good</td><td>91 (41.4)</td><td>(36.0)</td><td>(12.5)</td><td>H: 1.44</td><td></td></tr><tr><td>Intermediate</td>... |
c0147b4dacb9d84a4c0111a0ab594a377157c92d39103eef3d3587bf40f9e577.png | complex | <table><tr><td></td><td>N</td><td>M ± SD</td></tr><tr><td colspan="3">Outcome: Teaching quality<sup>a</sup></td></tr><tr><td> Didactics</td><td>499</td><td>7.9 ± 1.3</td></tr><tr><td> Learning climate</td><td>500</td><td>8.4 ± 1.1</td></tr><tr><td> Motivation and enthusiasm</td><td>500</td><td>8.1 ±... | <table><tr><td></td></tr><tr><td>Outcome: Teaching qualitya</td></tr><tr><td>Didactics</td></tr><tr><td>Learning climate</td></tr><tr><td>Motivation and enthusiasm</td></tr><tr><td>Behavior towards patients</td></tr><tr><td>Motivational categoriesb</td></tr><tr><td>Intrinsic TM</td></tr><tr><td>Identified TM</td></tr><... | <table><tr><td>N</td><td>M ± SD</td></tr><tr><td colspan="2">Outcome: Teaching qualitya</td></tr><tr><td>499</td><td>7.9 ± 1.3</td></tr><tr><td>500</td><td>8.4 ± 1.1</td></tr><tr><td>500</td><td>8.1 ± 1.3</td></tr><tr><td>488</td><td>8.1 ± 1.2</td></tr><tr><td>55 for all</td><td></td></tr><tr><td></td><td>2.7 ± 0.9</td... |
d0d24094639ef39b5d083c97682f5e65160a0ddd710e2242eb09a520bb539798.png | simple | <table><tr><td>Variant</td><td>Minor/major allele</td><td>Minor allele frequency</td></tr><tr><td>Genotyped and imputed</td><td> </td><td> </td></tr><tr><td>rs2206593</td><td>T/C</td><td>0.074</td></tr><tr><td>rs5275</td><td>C/T</td><td>0.317</td></tr><tr><td>rs10911905</td><td>G/T</td><td>0.084</td></tr><tr><td>rs2143... | <table><tr><td>Variant</td><td>Minor/major allele</td><td>Minor allele frequency</td></tr><tr><td>Genotyped and imputed</td><td></td><td></td></tr><tr><td>rs2206593</td><td>T/C</td><td>0.074</td></tr></table> | <table><tr><td>rs5275</td><td>C/T</td><td>0.317</td></tr><tr><td>rs10911905</td><td>G/T</td><td>0.084</td></tr><tr><td>rs2143417</td><td>T/G</td><td>0.100</td></tr><tr><td>Imputed</td><td></td><td></td></tr><tr><td>rs4648304</td><td>T/C</td><td>0.009</td></tr><tr><td>rs689470</td><td>T/C</td><td>0.016</td></tr><tr><td>... |
c02a053b9c9f2591ed87282ca742d2ce2f5a37bb25a521623e4c40016daaaff4.png | complex | <table><tr><td>Medical</td><td>Nursing</td></tr><tr><td><i>Enhanced scopes of practice</i></td><td></td></tr><tr><td>• Physicians are allowed to private practice with specific fees during off hours</td><td>• Nurses also are allowed to work in the private sector before and after office hours</td></tr><tr><td... | <table><tr><td>Me</td><td>Nursin</td></tr></table> | <table><tr><td>dical</td><td>g</td></tr><tr><td>Enhanced scopes of practice</td><td></td></tr><tr><td>• Physicians are allowed to private practice with specific fees during off hours</td><td>• Nurses also are allowed to work in the private sector before and after office hours</td></tr><tr><td>Producing new types of hea... |
e2d7a08636562c3b059be24b17e940dadfd366383b829c68d4c5580a2d3cdfbc.png | complex | <table><tr><td colspan="2">Hyphal size (μm)</td></tr><tr><td>Strain</td><td>Abscence of CE** vs. Presence of CE**</td></tr><tr><td>ATCC 90028</td><td>24.68 (24.68 ± 1.79) vs. 13.35 (13.35 ± 0.92)*</td></tr><tr><td>SC5314</td><td>30 (30 ± 2.47) vs. 16 (16 ± 1.16)*</td></tr><tr><td>Strain 01</td>... | <table><tr><td colspan="2">Hyphal size (μm)</td></tr><tr><td>Strain</td><td>Abscence of CE** vs. Presence of CE**</td></tr><tr><td>ATCC 90028</td><td>24.68 (24.68 ± 1.79) vs. 13.35 (13.35 ± 0.92)*</td></tr><tr><td>SC5314</td><td>30 (30 ± 2.47) vs. 16 (16 ± 1.16)*</td></tr><tr><td>Strain 01</td><td>21.67 (21.67 ± 1.39) ... | <table><tr><td>Strain 10Li</td><td>21.25 (21.25 ± 1.87) vs. 11.73 (11.73 ± 0.92)*</td></tr><tr><td>Strain 111R</td><td>36.15 (36.15 ± 2.56) vs. 25.06 (25.06 ± 1.34)*</td></tr></table> |
be1af8a9d5b7cd17867b77ae3079b5fcb48a04132a73776592637de51d7d7c90.png | complex | <table><tr><td></td><td colspan="3">W</td><td colspan="3">AS</td><td>Vigilance state effect</td><td>Period effect</td></tr><tr><td>Period</td><td><i>control</i></td><td><i>prior</i></td><td><i>during</i></td><td><i>control</i></td><td><i>prior</i></td><td><i>during</i></td><td colspan="2"><i>P</i></td></tr><tr><td>Tota... | <table><tr><td></td><td colspan="3">W</td><td>AS</td></tr><tr><td>Period</td><td>control</td><td>prior</td><td>during</td><td>control</td></tr><tr><td>Total V, s2</td><td>0.069±0.069</td><td>0.055±0.058</td><td>0.074±0.068</td><td>0.054±0.061</td></tr><tr><td>LF, s2</td><td>0.026±0.024</td><td>0.021±0.020</td><td>0.027... | <table><tr><td colspan="2">AS</td><td>Vigilance state effect</td><td>Period effect</td></tr><tr><td>prior</td><td>during</td><td colspan="2">P</td></tr><tr><td>0.050±0.052</td><td>0.056±0.059</td><td>0.008</td><td>0.060</td></tr><tr><td>0.020±0.020</td><td>0.022±0.022</td><td>0.016</td><td>NS</td></tr><tr><td>0014±0.02... |
5b673f4ecbd778b9f40f2d74c310f91406bd06c95938093d2fb490fcf089fad3.png | complex | <table><tr><td>Objection</td><td>Primer</td><td>Sequences</td></tr><tr><td rowspan="2">Murine variable regions of the heavy chain (V<sub>H</sub>)</td><td>VHF</td><td>5'-GCTGCCCAACCAGCCATGGCCGAGGTGCAGCTGGTGGAATCGGG-3'</td></tr><tr><td>VHR</td><td>5'-CGATGGGCCCTTGGTGGAGGCTGCAGAGACAGTGACCAGAGT-3'</td></tr><tr><td rowspan=... | <table><tr><td>Objection</td><td>Primer</td><td>Sequences</td></tr><tr><td rowspan="2">Murine variable regions of the heavy chain (VH)</td><td>VHF</td><td>5'-GCTGCCCAACCAGCCATGGCCGAGGTGCAGCTGGTGGAATCGGG-3'</td></tr><tr><td>VHR</td><td>5'-CGATGGGCCCTTGGTGGAGGCTGCAGAGACAGTGACCAGAGT-3'</td></tr><tr><td rowspan="2">Murine ... | <table><tr><td>Human constant regions of the heavy chain domain 1 (CH1)</td><td>dpseq</td><td>5'-GATATCAGAAGCGTAGTCCGGAACGTC-3'</td></tr><tr><td rowspan="2">Human constant regions of the light chain domain (CL)</td><td>HKC-F</td><td>5'-CGAACTGTGGCTGCACCATCTGTC-3'</td></tr><tr><td>Lead B</td><td>5'-AAGCTTGGCCATGGCTGGTTG... |
2fccd9407b51d11639f580792bcc8d7d5d35fbb9feca3f144d2371a1f458007b.png | complex | <table><tr><td></td><td></td><td>Number of participants (% within category)</td></tr><tr><td rowspan="2">Country of graduation and current workplace</td><td>Rwanda</td><td>13 (76%)</td></tr><tr><td>Democratic Republic of the Congo</td><td>4 (24%)</td></tr><tr><td rowspan="3">Completed whole years since graduation</td><... | <table><tr><td></td><td></td><td>Number of participants (% within category)</td></tr><tr><td rowspan="2">Country of graduation and current workplace</td><td>Rwanda</td><td>13 (76%)</td></tr><tr><td>Democratic Republic of the Congo</td><td>4 (24%)</td></tr><tr><td rowspan="3">Completed whole years since graduation</td><... | <table><tr><td></td><td></td><td>Number of participants (% within category)</td></tr><tr><td>Desired future specialty</td><td>Urology</td><td>2 (12%)</td></tr></table> |
0b6b71a2ae46f5953fe9ceb3a3861cf2968bc65d55244dcc0d63c9de3cc8c97d.png | complex | <table><tr><td>Characteristics</td><td>N</td><td>Total (%)</td><td>Boys (%)</td><td>Girls (%)</td><td>χ<sup>2</sup></td><td><i>p</i>-value</td></tr><tr><td>Sexually active</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>113</td><td>27.2</td><td>33.8</td><td>21.3</td><td rowspan="... | <table><tr><td>Characteristics</td><td>N</td><td>Total (%)</td><td>Boys (%)</td><td>Girls (%)</td><td>χ2</td><td>p-value</td></tr><tr><td>Sexually active</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>113</td><td>27.2</td><td>33.8</td><td>21.3</td><td rowspan="2">8.29</td><td rowspan... | <table><tr><td>Characteristics</td><td>N</td><td>Total (%)</td><td>Boys (%)</td><td>Girls (%)</td><td>χ2</td><td>p-value</td></tr><tr><td>One</td><td>59</td><td>57.8</td><td>50</td><td>68.2</td><td rowspan="2">3.39</td><td rowspan="2">0.07</td></tr><tr><td>More than one</td><td>43</td><td>42.2</td><td>50</td><td>31.8</... |
f52ff2db1ac57253dec1dd9bd9deb3e095ba5c40e249640ed6d3479eecc53d17.png | simple | <table><tr><td>Parameters</td><td>Patients with T1DM(n = 162)</td><td>controls(n = 80)</td><td><i>P</i>- value</td></tr><tr><td>Age (years)</td><td>19.35 ± 2.6</td><td>19.76 ± 2.76</td><td>0.3</td></tr><tr><td>Females (%)</td><td>55.5% (90/162)</td><td>55% (44/80)</td><td>0.93</td></tr><tr><td>Gastrointestina... | <table><tr><td>Parameters</td><td>Patients with T1DM(n = 162)</td><td>controls(n = 80)</td><td>P- value</td></tr><tr><td>Age (years)</td><td>19.35 ± 2.6</td><td>19.76 ± 2.76</td><td>0.3</td></tr><tr><td>Females (%)</td><td>55.5% (90/162)</td><td>55% (44/80)</td><td>0.93</td></tr><tr><td>Gastrointestinal symptoms</td><t... | <table><tr><td>Duration of diabetes (years)</td><td>7.29 ± 7.9</td><td>_</td><td></td></tr><tr><td>HbA1c (%)</td><td>8.2 ± 1.75</td><td>_</td><td></td></tr></table> |
323bc4148ab84c602a11500c093019f7d42a05b3ee2ad737d238ad309a4d3c69.png | complex | <table><tr><td>CME activity</td><td>Activity 2</td><td>Activity 3</td></tr><tr><td>Sample size</td><td>n=1237</td><td>n=611</td></tr><tr><td colspan="3">Responses to: Practitioners are asked to report drug adverse events:</td></tr><tr><td colspan="3">A. To MedWatch</td></tr><tr><td colspan="3">B. Only when the adverse ... | <table><tr><td>CME activity</td></tr><tr><td>Sample size</td></tr><tr><td>Responses to: Practitioners are asked to report drug adverse events:</td></tr><tr><td>A. To MedWatch</td></tr><tr><td>B. Only when the adverse event is not specified on the drug label</td></tr><tr><td>C. Within 30 days of occurrence, as required ... | <table><tr><td>Activity 2</td><td>Activity 3</td></tr><tr><td>n=1237</td><td>n=611</td></tr><tr><td colspan="2">Responses to: Practitioners are asked to report drug adverse events:</td></tr><tr><td colspan="2">A. To MedWatch</td></tr><tr><td colspan="2">B. Only when the adverse event is not specified on the drug label<... |
a9b71a95ab93d0829cbe6ac85314bb28540f66fa3eb0c036ff82570f9920df7a.png | complex | <table><tr><td>Presyn</td><td>Postsyn</td><td>Type</td><td>Conv</td><td>Div</td><td># Synapses</td></tr><tr><td>MF</td><td>Glom</td><td>Excitatory</td><td>1</td><td>20</td><td>5000</td></tr><tr><td>Glom</td><td>GR</td><td>Excitatory</td><td>4</td><td>53</td><td>262,400</td></tr><tr><td>Glom</td><td>GO</td><td>Excitator... | <table><tr><td>Presyn</td><td>Postsyn</td><td>Type</td><td>Conv</td><td>Div</td><td># Synapses</td></tr><tr><td>MF</td><td>Glom</td><td>Excitatory</td><td>1</td><td>20</td><td>5000</td></tr><tr><td>Glom</td><td>GR</td><td>Excitatory</td><td>4</td><td>53</td><td>262,400</td></tr><tr><td>Glom</td><td>GO</td><td>Excitator... | <table><tr><td>PC</td><td>DCN</td><td>Inhibitory</td><td>40</td><td>5</td><td>2,000</td></tr><tr><td>DCN (30%)</td><td>IO</td><td>Inhibitory</td><td>0.34</td><td>1</td><td>14</td></tr><tr><td>IO</td><td>DCN</td><td>Excitatory</td><td>1</td><td>1,41</td><td>50</td></tr><tr><td>MF</td><td>DCN</td><td>Excitatory</td><td>1... |
89f96d4d758de4c43f8e043b9e1e4f9b3dc77b0694c13cf2ca02a13ab3e832c0.png | simple | <table><tr><td>Transporters</td><td>Organism</td><td>Cells/Tissue</td><td>Cargo (proteins) specific to each importin or exportin</td><td>Reference</td></tr><tr><td>Importin <i>α</i>1</td><td>Human</td><td>ROS 17/2.8, UMR-106, MC3T3-E1, and SaOS-2</td><td>Type 1 parathyroid hormone receptor</td><td>[62]</td></tr><t... | <table><tr><td>Transporters</td><td>Organism</td><td>Cells/Tissue</td><td>Cargo (proteins) specific to each importin or exportin</td><td>Reference</td></tr><tr><td>Importin α1</td><td>Human</td><td>ROS 17/2.8, UMR-106, MC3T3-E1, and SaOS-2</td><td>Type 1 parathyroid hormone receptor</td><td>[62]</td></tr><tr><td>Import... | <table><tr><td>Importin 8</td><td>Human</td><td>HaCaTCOS-1</td><td>SMADsSignal recognition particle protein 19</td><td>[76, 77]</td></tr><tr><td>Importin 9</td><td>Human</td><td>HeLa</td><td>c-JunPP2A (PR65)</td><td>[71][78]</td></tr><tr><td>Importin 11</td><td>Human</td><td>BHK</td><td>L12UbcM2</td><td>[79, 80]</td></... |
09eecd839f30445fe510bbd5e7097c845d907884e5f6db96edbe99346a098d1b.png | complex | <table><tr><td></td><td></td><td>Total (N = 2,984)</td><td colspan="3">Healthcare care utilization in the past 12 months (<i>n</i> = 1,978)</td><td colspan="3">Any marital violence in the past 12 months (<i>n</i> = 834)</td></tr><tr><td></td><td></td><td>%<sup>a</sup></td><td>Prevalence %<sup>b</sup></td><td>Χ<sup... | <table><tr><td></td><td></td><td>Total (N = 2,984)</td><td colspan="3">Healthcare care utilization in the past 12 months (n = 1,978)</td><td colspan="3">Any marital violence in the past 12 months (n = 834)</td></tr><tr><td></td><td></td><td>%a</td><td>Prevalence %b</td><td>Χ2 (DF)</td><td>p value</td><td>Prevalence %b<... | <table><tr><td>Marital violence</td><td>None</td><td>72.1</td><td>65.1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="3">Education</td><td>Jr. high/high</td><td>27.0</td><td>62.4</td><td>13.56 (2)</td><td>0.001*</td><td>29.7</td><td>2.34 (2)</td><td>0.310</td></tr><tr><td>College</td><td>31.3</t... |
3ae7f0b10352db97420a8667b0d8722358ada5afae5a7daa0813ad315af6b325.png | complex | <table><tr><td rowspan="2">Characteristics (n)</td><td colspan="3">DR5</td><td colspan="3">DR4</td></tr><tr><td>+ (%)</td><td>−(%)</td><td>P-value</td><td>+ (%)</td><td>−(%)</td><td>P-value</td></tr><tr><td>Age (yr)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> ≤40 (n=59)</td... | <table><tr><td rowspan="2">Characteristics (n)</td><td colspan="3">DR5</td><td colspan="3">DR4</td></tr><tr><td>+ (%)</td><td>−(%)</td><td>P-value</td><td>+ (%)</td><td>−(%)</td><td>P-value</td></tr><tr><td>Age (yr)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≤40 (n=59)</td><td>21(35.6)</td><... | <table><tr><td rowspan="2">Characteristics (n)</td><td colspan="3">DR5</td><td colspan="3">DR4</td></tr><tr><td>+ (%)</td><td>−(%)</td><td>P-value</td><td>+ (%)</td><td>−(%)</td><td>P-value</td></tr><tr><td>N status</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>LNM (n=124)</td><td>36(29.0)</td>... |
41bd071b8a871b4a0adecfd08800b470bb1c8e0fee8a46beb49f6046585ef5f4.png | simple | <table><tr><td>Viruses</td><td>F1140O2-5 VP3</td><td>F11VP2O-2 VP2</td><td>F12VP1O-2 Site 1b</td><td>F21-48 Site 1a,5</td><td>F21-64 Site 1a,5</td><td>F21-34 Site 2</td><td>F21-58 Site 2</td><td>F21-41 Site 3</td><td>F21-18 Near site 4</td></tr><tr><td>ECU/4/2010</td><td>0.10</td><td>1.07</td><td>0.49</td><td>1.42</td>... | <table><tr><td>Viruses</td><td>F1140O2-5 VP3</td><td>F11VP2O-2 VP2</td><td>F12VP1O-2 Site 1b</td><td>F21-48 Site 1a,5</td><td>F21-64 Site 1a,5</td></tr><tr><td>ECU/4/2010</td><td>0.10</td><td>1.07</td><td>0.49</td><td>1.42</td><td>0.45</td></tr><tr><td>HKN/2/2011</td><td>1.21</td><td>-0.02</td><td>1.12</td><td>0.25</td... | <table><tr><td>F21-34 Site 2</td><td>F21-58 Site 2</td><td>F21-41 Site 3</td><td>F21-18 Near site 4</td></tr><tr><td>-0.004</td><td>0.014</td><td>1.76</td><td>0.014</td></tr><tr><td>0.05</td><td>0.02</td><td>1.36</td><td>0.05</td></tr><tr><td>0.15</td><td>0.04</td><td>1.44</td><td>1.39</td></tr><tr><td>1.11</td><td>1.1... |
7dce2dba7c15c8b1eba72f89d1dc3287bdc13c5c093edae689cbbd590fa4f190.png | complex | <table><tr><td>Maternal Infection Status</td><td>Incidence rate per 100 pyrs (95% CI)</td><td>Cox HR (95% CI)</td><td>Adjusted HR<sup>a</sup> (95% CI)</td><td><i>P</i> Value</td><td>Adjusted HR<sup>b</sup> (95% CI)</td><td><i>P</i> Value</td></tr><tr><td colspan="7">No malaria</td></tr><tr><td> No hookworm</td><td>28.8... | <table><tr><td>Maternal Infection Status</td></tr><tr><td>No malaria</td></tr><tr><td>No hookworm</td></tr><tr><td>Hookworm</td></tr><tr><td>Had malaria</td></tr><tr><td>No hookworm</td></tr><tr><td>Hookworm</td></tr><tr><td>Pinteraction = .23c</td></tr><tr><td>No malaria</td></tr><tr><td>No Mansonella perstans</td></t... | <table><tr><td>Incidence rate per 100 pyrs (95% CI)</td><td>Cox HR (95% CI)</td><td>Adjusted HRa (95% CI)</td><td>P Value</td><td>Adjusted HRb (95% CI)</td><td>P Value</td></tr><tr><td colspan="6">No malaria</td></tr><tr><td>28.81 (27.33,30.38)</td><td>1</td><td>1</td><td></td><td>1</td><td></td></tr><tr><td>37.93 (35.... |
374b0f745be97fc0c822a282edc757c53fe90c783c14dd3a533f9ef2f8af60be.png | simple | <table><tr><td>Video</td><td>CT</td><td>DFT</td><td>ORIA</td><td>MTT</td><td>ASLA</td><td>L1APG</td><td>SCM</td><td>MIL</td><td>MCT</td></tr><tr><td><i>Basketball</i></td><td>0.278</td><td>0.604</td><td>0.072</td><td>0.223</td><td>0.398</td><td>0.256</td><td>0.475</td><td>0.247</td><td>0.526</td></tr><tr><td><i>Boy</i>... | <table><tr><td>Video</td><td>CT</td><td>DFT</td><td>ORIA</td><td>MTT</td><td>ASLA</td><td>L1APG</td><td>SCM</td><td>MIL</td><td>MCT</td></tr><tr><td>Basketball</td><td>0.278</td><td>0.604</td><td>0.072</td><td>0.223</td><td>0.398</td><td>0.256</td><td>0.475</td><td>0.247</td><td>0.526</td></tr><tr><td>Boy</td><td>0.587... | <table><tr><td>Average</td><td>0.378</td><td>0.361</td><td>0.295</td><td>0.425</td><td>0.440</td><td>0.403</td><td>0.467</td><td>0.357</td><td>0.650</td></tr></table> |
8d4bd9f3f098b24a42358454140ef1bd6e479b32862351611f72d2a94b71407f.png | simple | <table><tr><td>Metric</td><td>Target Performance</td></tr><tr><td>HC</td><td>Communication latency and energy consumption reduction (indirectly)</td></tr><tr><td>ETX</td><td>Reduction of required frame retransmissions</td></tr><tr><td>RE</td><td>Expansion of network lifetime</td></tr><tr><td>PFI</td><td>Reduction of ne... | <table><tr><td>Metric</td><td>Target Performance</td></tr><tr><td>HC</td><td>Communi</td></tr></table> | <table><tr><td></td><td>cation latency and energy consumption reduction (indirectly)</td></tr><tr><td>ETX</td><td>Reduction of required frame retransmissions</td></tr><tr><td>RE</td><td>Expansion of network lifetime</td></tr><tr><td>PFI</td><td>Reduction of network-layer losses</td></tr><tr><td>ETT</td><td>Assignment o... |
2c8547b73196b03e83afd5c0fe765440be0bb330fda433cc8e16bdc4d5283379.png | complex | <table><tr><td>Variable</td><td>Perc. difference (with - without OB)</td><td>Difference (with - without OB)</td><td>t-stats</td></tr><tr><td>Hourly Revenue (Eur)</td><td>15.4</td><td>6.9</td><td>2.76</td></tr><tr><td>Waiting time (Min)</td><td>3.66</td><td>6.2</td><td>0.34</td></tr><tr><td>Idle time (Min)</td><td>ͨ... | <table><tr><td>Variable</td><td>Perc. difference (with - without OB)</td><td>Difference (with - without OB)</td><td>t-stats</td></tr><tr><td>Hourly Revenue (Eur)</td><td>15.4</td><td>6.9</td><td>2.76</td></tr><tr><td>Waiting time (Min)</td><td>3.66</td><td>6.2</td><td>0.34</td></tr><tr><td>Idle </td><td>−1.</td><td></t... | <table><tr><td>time (Min)</td><td>42</td><td>−9.1</td><td></td></tr><tr><td>Overtime (Min)</td><td>4.05</td><td>10</td><td>0.3</td></tr><tr><td colspan="2">Number of days with OB</td><td>112</td><td></td></tr><tr><td colspan="2">of days without OB</td><td>62</td><td></td></tr></table> |
cef2d7fad89a606e7d2b826e1c6b5571fb45d2fdf0875985a88a2a0421bae66f.png | simple | <table><tr><td>Task</td><td>Search</td><td>Share</td><td>Read</td><td>Repeat</td><td>Comp man</td><td>Comp auto</td><td>Query</td><td>Analyse</td><td>Browse</td><td>Populate</td></tr><tr><td>Importance</td><td>Low</td><td>Med</td><td>Med</td><td>High</td><td>Low</td><td>High</td><td>Low</td><td>Low</td><td>Low</td><td>... | <table><tr><td>Task</td><td>Search</td><td>Share</td><td>Read</td><td>Repeat</td><td>Comp man</td><td>Comp auto</td><td>Query</td><td>Analyse</td><td>Browse</td><td>Populate</td></tr><tr><td>Impor</td><td>Lo</td><td>M</td><td>Me</td><td>Hi</td><td>Low</td><td>Hig</td><td></td><td>Lo</td><td>Lo</td><td>Me</td></tr></tab... | <table><tr><td>tance</td><td>w</td><td>ed</td><td>d</td><td>gh</td><td></td><td>h</td><td>Low</td><td>w</td><td>w</td><td>d</td></tr></table> |
da2ca70c07c0aaf8df891e125312d02b396471d90ef5355e10f08970efa8708d.png | complex | <table><tr><td> </td><td colspan="3">Proteinuria negative (<i>n</i> = 13)</td><td colspan="3">Proteinuria positive (<i>n</i> = 67)</td><td rowspan="2"><i>p</i> value</td></tr><tr><td> </td><td>Median</td><td>(min–max)</td><td>IQR</td><td>Median</td><td>(min–max)</td><td>IQR</td></tr><tr><td><sup>*</sup>Syst... | <table><tr><td></td><td colspan="3">Proteinuria negative (n = 13)</td><td colspan="3">Proteinuria positive (n = 67)</td><td rowspan="2">p value</td></tr><tr><td></td><td>Median</td><td>(min–max)</td><td>IQR</td><td>Median</td><td>(min–max)</td><td>IQR</td></tr><tr><td>*Systolic blood pressure</td><td>117</td><td>103–13... | <table><tr><td></td><td colspan="3">Proteinuria negative (n = 13)</td><td colspan="3">Proteinuria positive (n = 67)</td><td rowspan="2">p value</td></tr><tr><td></td><td>Median</td><td>(min–max)</td><td>IQR</td><td>Median</td><td>(min–max)</td><td>IQR</td></tr><tr><td>Aortic distensibility</td><td>2,93</td><td>1,56–14,... |
e71846bbbbd965fe5df5660d56606908e2e189e4f071302571db634808371af9.png | complex | <table><tr><td>Feeding model*</td><td colspan="3">Time of measurement</td><td>Reference</td></tr><tr><td></td><td>2 h</td><td>4, 5, or 6 h</td><td>24 h</td><td></td></tr><tr><td colspan="5">MCH-INDUCED HYPERPHAGIA IN RAT</td></tr><tr><td>Male Sprague-Dawley</td><td></td><td>−90%</td><td></td><td>Takekawa et al. (... | <table><tr><td>Feeding model*</td><td colspan="3">Time of measurement</td><td>Reference</td></tr><tr><td></td><td>2 h</td><td>4, 5, or 6 h</td><td>24 h</td><td></td></tr><tr><td colspan="5">MCH-INDUCED HYPERPHAGIA IN RAT</td></tr><tr><td>Male Sprague-Dawley</td><td></td><td>−90%</td><td></td><td>Takekawa et al. (2002)<... | <table><tr><td>DIO male F344/Jcl rats</td><td></td><td>−28%</td><td></td><td>Kasai et al. (2011)</td></tr><tr><td>DIO male Sprague-Dawley rats</td><td></td><td></td><td>−31%</td><td>Kowalski and Sasikumar (2007)</td></tr><tr><td>Male Sprague-Dawley rats, ingestion of condensed milk#</td><td>−45%</td><td></td><td></td><... |
2993354125a0bd6321bc154402a11a6f0bd09bbcc9dd535d42d93ec6462ee9c4.png | complex | <table><tr><td></td><td>50–59 yrs</td><td>60-69 yrs</td><td><i>≥</i>70 yrs</td></tr><tr><td>Patients</td><td>1310</td><td>1180</td><td>726</td></tr><tr><td colspan="4">Cases of vertebral fracture</td></tr><tr><td> n, (%)</td><td>31(2.37%)#△</td><td>105(8.90%)*△</td><td>159(21.90%)*#</td></tr></t... | <table><tr><td></td><td>50–59 yrs</td><td>60-69 yrs</td><td>≥70 yrs</td></tr><tr><td>Patients</td><td>1310</td><td>1180</td><td>726</td></tr><tr><td colspan="4">Cases of vertebral fracture</td></tr></table> | <table><tr><td>n, (%)</td><td>31(2.37%)#△</td><td>105(8.90%)*△</td><td>159(21.90%)*#</td></tr></table> |
b1dbc8fe91dcde17d52462dccff79a36dca9ff1113dfc3b7f722f90811edc711.png | simple | <table><tr><td></td><td>Number of ACT</td><td>% first-line treatment</td></tr><tr><td>Benin</td><td>95</td><td>83.2</td></tr><tr><td>DRC</td><td>131</td><td>67.9</td></tr><tr><td>Madagascar</td><td>83</td><td>76.9</td></tr><tr><td>Nigeria</td><td>171</td><td>88.1</td></tr><tr><td>Uganda</td><td>360</td><td>100.0</td></... | <table><tr><td></td><td>Number of ACT</td><td>% first-line treatment</td></tr><tr><td>Benin</td><td>95</td><td>83.2</td></tr></table> | <table><tr><td></td><td>Number of ACT</td><td>% first-line treatment</td></tr><tr><td>DRC</td><td>131</td><td>67.9</td></tr><tr><td>Madagascar</td><td>83</td><td>76.9</td></tr><tr><td>Nigeria</td><td>171</td><td>88.1</td></tr><tr><td>Uganda</td><td>360</td><td>100.0</td></tr><tr><td>Zambia</td><td>380</td><td>99.5</td>... |
ed729d7f102d875b67629de748edeb6be78ccd8628e0013d727e4dd5d6c03017.png | simple | <table><tr><td></td><td>Bone 1</td><td>Bone 2</td><td>Bone 3</td><td>Bone 4</td><td>Bone 5</td><td>Bone 6</td><td>Bone 7</td></tr><tr><td>Bone 1</td><td>-</td><td>NS</td><td>NS</td><td>NS</td><td>S</td><td>NS</td><td>NS</td></tr><tr><td>Bone 2</td><td>NS</td><td>-</td><td>NS</td><td>NS</td><td>S</td><td>NS</td><td>NS</... | <table><tr><td></td><td>Bone 1</td><td>Bone 2</td><td>Bone 3</td><td>Bone 4</td><td>Bone 5</td><td>Bone 6</td><td>Bone 7</td></tr><tr><td>Bone 1</td><td>-</td><td>NS</td><td>NS</td><td>NS</td><td>S</td><td>NS</td><td>NS</td></tr><tr><td>Bone 2</td><td>NS</td><td>-</td><td>NS</td><td>NS</td><td>S</td><td>NS</td><td>NS</... | <table><tr><td>Bone 4</td><td>NS</td><td>NS</td><td>NS</td><td>-</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Bone 5</td><td>S</td><td>S</td><td>S</td><td>NS</td><td>-</td><td>S</td><td>NS</td></tr><tr><td>Bone 6</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>S</td><td>-</td><td>NS</td></tr><tr><td>Bone 7</td... |
ddb986aaffc629f08a3ba37a38d6cb1c46a52e9ce619395f7978a1a038202d73.png | simple | <table><tr><td></td><td>All patients (n = 146)</td><td>QoL group (n = 81)</td></tr><tr><td>Age [years]</td><td>44 (13 - 74)</td><td>46 (16-74)</td></tr><tr><td>Gender ratio (male : female)</td><td>37 (25.3%) : 109 (74.7%)</td><td>16 (19.8%) : 65 (80.2%)</td></tr><tr><td>Tumor size [mm]</td><td>65 (10 - 230)</td><td>70 ... | <table><tr><td></td><td>All pati</td><td>Qo</td></tr></table> | <table><tr><td></td><td>ents (n = 146)</td><td>L group (n = 81)</td></tr><tr><td>Age [years]</td><td>44 (13 - 74)</td><td>46 (16-74)</td></tr><tr><td>Gender ratio (male : female)</td><td>37 (25.3%) : 109 (74.7%)</td><td>16 (19.8%) : 65 (80.2%)</td></tr><tr><td>Tumor size [mm]</td><td>65 (10 - 230)</td><td>70 (8 - 230)<... |
736d09472e29a3c384de067d9909d57bf2222d98c94f73da13c9f7d45a0b4025.png | complex | <table><tr><td>Variables</td><td>UC (<i>N</i> = 181)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>107 (59.1%)</td></tr><tr><td>Age at UC diagnosis (years), median (IQR)</td><td>35.8 (26.1–47.8)</td></tr><tr><td>Age at FC level measurement (years), median (IQR)</td><td>40.5 (29.2–53.8)</td... | <table><tr><td>Variables</td><td>UC (N = 181)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Male</td><td>107 (59.1%)</td></tr><tr><td>Age at UC diagnosis (years), median (IQR)</td><td>35.8 (26.1–47.8)</td></tr><tr><td>Age at FC level measurement (years), median (IQR)</td><td>40.5 (29.2–53.8)</td></tr><tr><td>Diseas... | <table><tr><td>Variables</td><td>UC (N = 181)</td></tr><tr><td>Proctitis</td><td>33 (18.2%)</td></tr><tr><td>Left-sided colitis</td><td>47 (26.0%)</td></tr><tr><td>Extensive colitis</td><td>101 (55.8%)</td></tr><tr><td colspan="2">Disease severity of UC</td></tr><tr><td>Clinical remission (Mayo score 0-2)</td><td>17 (9... |
91415fc249621457b773a585d495834e7d76ffde0e1dca3281f7426a4f801ffb.png | simple | <table><tr><td>Authors (year), country</td><td>Participants</td><td>Tool (cut-off if provided)</td><td>Results</td></tr><tr><td>Burch et al. (2008) [63], South AfricaRisk of bias: High</td><td>790</td><td>MEWS</td><td>Hospital admissionMEWS 0–2 (ref)MEWS 3–4: RR 1.3 (95% CI 1.1 to 1.6)MEWS ≥5: RR 1.7 ... | <table><tr><td>Authors (year), country</td><td>Participants</td><td>Tool (cut-off if provided)</td></tr><tr><td>Burch et al. (2008) [63], South AfricaRisk of bias: High</td><td>790</td><td>MEWS</td></tr><tr><td>Correia et al. (2014) [55], PortugalRisk of bias: Unclear</td><td>65</td><td>EWS</td></tr><tr><td>Dundar et a... | <table><tr><td>Results</td></tr><tr><td>Hospital admissionMEWS 0–2 (ref)MEWS 3–4: RR 1.3 (95% CI 1.1 to 1.6)MEWS ≥5: RR 1.7 (95% CI 1.5 to 2.0)In-hospital mortalityMEWS 0–2 (ref)MEWS 3–4: RR 2.8 (95% CI 1.7 to 4.8)MEWS ≥5: RR 4.6 (95% CI 2.7 to 7.8)</td></tr><tr><td>Length of hospital stay & MortalityScore at 24 h and ... |
c89c0882cc4a3b75cccb151c84cf099d267aba476017109a5894b65e9fe326a8.png | simple | <table><tr><td>Models (Prevent/Treatment)</td><td>Antioxidant/Plants</td><td>Effects</td><td>Dose (Dose-Effect)</td><td>Bioactive Compounds</td><td>References</td></tr><tr><td>Diabetic rats fed on a high fat thermolyzed diet (Prevent)</td><td>Omega 3-polyunsaturated fatty acids</td><td>↑ SOD, CAT; ↓ triglyc... | <table><tr><td>Models (Prevent/Treatment)</td><td>Antioxidant/Plants</td><td>Effects</td><td>Dose (Dose-Effect)</td><td>Bioactive Compounds</td><td>References</td></tr><tr><td>Diabetic rats fed on a high fat </td><td>Omega 3-polyunsaturated fa</td><td>↑ SOD, CAT; ↓ triglycerides, non</td><td></td><td>Omega 3-polyunsatu... | <table><tr><td>Models (Prevent/Treatment)</td><td>Antioxidant/Plants</td><td>Effects</td><td>Dose (Dose-Effect)</td><td>Bioactive Compounds</td><td>References</td></tr><tr><td>thermolyzed diet (Prevent)</td><td>tty acids</td><td>-esterified fatty acid, lipoperoxidation</td><td>3.0% in diet</td><td>atty acids</td><td>08... |
0adcb9f3927b740150be8331a5824d54c0a845ed3509f3fb8655c68fb0871ad2.png | complex | <table><tr><td></td><td colspan="3">Before The Establishment of Trauma Team</td><td colspan="3">After The Establishment of Trauma Team</td><td></td><td></td></tr><tr><td></td><td>n</td><td>Average</td><td>SD</td><td>n</td><td>Average</td><td>SD</td><td>t</td><td>p</td></tr><tr><td>ICU stay</td><td>47</td><td>7.81</td><... | <table><tr><td></td><td colspan="3">Before The Establishment of Trauma Team</td><td colspan="3">After The Establishment of Trauma Team</td><td></td><td></td></tr><tr><td></td><td>n</td><td>Average</td><td>SD</td><td>n</td><td>Average</td><td>SD</td><td>t</td><td>p</td></tr><tr><td>ICU stay</td><td>47</td><td>7.81</td><... | <table><tr><td>Operation waiting time</td><td>17</td><td>37.47</td><td>19.71</td><td>16</td><td>33.75</td><td>58.20</td><td>.249</td><td>0.805</td></tr><tr><td>Duration stay in ER</td><td>17</td><td>290.65</td><td>353.06</td><td>16</td><td>180.75</td><td>141.35</td><td>1.160</td><td>0.255</td></tr><tr><td>Clinical Char... |
a88592075193858ca2c6e55fd046401aefe0fdccecafec6e72503acbca6edb14.png | complex | <table><tr><td>Questions for nurse practitioners</td><td>Questions for senior doctors and nurses</td></tr><tr><td>1. How would you describe your role?</td><td>1. What is your understanding of the role of the NP?</td></tr><tr><td>2. How is the role of a Nurse Practitioner (NP) different from that of doctors and other nu... | <table><tr><td>Questions for nurse practitioners</td><td>Questions for senior doctors and nurses</td></tr><tr><td>1. How would you describe your role?</td><td>1. What is your understanding of the role of the NP?</td></tr><tr><td>2. How is the role of a Nurse Practitioner (NP) different from that of doctors and other nu... | <table><tr><td>4. Do you think the roles of NPs would differ at other sites?</td><td rowspan="2">5. What is your view on the overlap between NP roles and those of doctors?</td></tr><tr><td>− Why do you think they would differ? (e.g. due to ICT, casemix, culture etc.)</td></tr><tr><td>− What are the mechanisms which det... |
1595724d2a791abf035bd527e976a6cea9b6176278e7c56186eb6a2c2a7399a0.png | complex | <table><tr><td rowspan="2">Variables (mm)</td><td rowspan="2"></td><td colspan="3">Δ(T2 − T1)</td></tr><tr><td>Mean</td><td>SD</td><td><i>p</i> value</td></tr><tr><td></td><td>UP(y) (mm)</td><td>−1.24</td><td>1.84</td><td>0.049*</td></tr><tr><td></td><td>Stm(y) (mm)</td><td>0.63</td><td>1.17</td><td>0.... | <table><tr><td rowspan="2">Variables (mm)</td><td rowspan="2"></td><td colspan="2">Δ(T2 − T1)</td></tr><tr><td>Mean</td><td>SD</td></tr><tr><td></td><td>UP(y) (mm)</td><td>−1.24</td><td>1.84</td></tr><tr><td></td><td>Stm(y) (mm)</td><td>0.63</td><td>1.17</td></tr><tr><td></td><td>Stm(z) (mm)</td><td>−1.79</td><td>2.48<... | <table><tr><td>Δ(T2 − T1)</td></tr><tr><td>p value</td></tr><tr><td>0.049*</td></tr><tr><td>0.103</td></tr><tr><td>0.003**</td></tr><tr><td>0.001**</td></tr><tr><td>0.025*</td></tr><tr><td>0.000**</td></tr><tr><td>0.371</td></tr><tr><td>0.016*</td></tr><tr><td>0.065*</td></tr><tr><td>0.201</td></tr></table> |
2aee90421f644aec35529b761277de8300b178e68696fedf0549a5f42d9d2cc0.png | complex | <table><tr><td>Demographic characteristics</td><td>Consented to biobanking (<i>n</i> = 2,100)</td><td>Refused or withdrew (<i>n</i> = 75)</td><td><i>p</i>-Value</td></tr><tr><td>Father’s age; mean (SD)</td><td>39.1 (38.8–39.5)</td><td>41.3 (39.6–42.9)</td><td>0.034</td></tr><tr><td>Mother’s age;... | <table><tr><td>Demographic characteristics</td><td>Consented to biobanking (n = 2,100)</td><td>Refused or withdrew (n = 75)</td><td>p-Value</td><td rowspan="2" colspan="8"></td></tr><tr><td>Father’s age; mean (SD)</td><td>39.1 (38.8–39.5)</td><td>41.3 (39.6–42.9)</td><td>0.034</td></tr></table> | <table><tr><td>Demographic characteristics</td><td>Consented to biobanking (n = 2,100)</td><td>Refused or withdrew (n = 75)</td><td>p-Value</td><td rowspan="2" colspan="8"></td></tr><tr><td>Mother’s age; mean (SD)</td><td>33.1 (32.9–33.5)</td><td>34.8 (33.1–36.5)</td><td>0.056</td></tr><tr><td colspan="4">Mother’s leve... |
8a92658a03d340d28a4e1a2141484221ab23b5badd4239a5a078ac58079704ac.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Splenic aspirate parasitologic result</td><td rowspan="2">Total</td></tr><tr><td>Negative</td><td>Positive</td></tr><tr><td colspan="4">rK39 ICT strip test</td></tr><tr><td> Negative</td><td>5</td><td>7</td><td>12</td></tr><tr><td> Positive</td><td>13</td><td>37</td><td>5... | <table><tr><td rowspan="2"></td><td colspan="2">Splenic aspirate parasitologic result</td><td rowspan="2">Total</td></tr><tr><td>Negative</td><td>Positive</td></tr><tr><td colspan="4">rK39 ICT strip test</td></tr><tr><td>Negative</td><td>5</td><td>7</td><td>12</td></tr></table> | <table><tr><td rowspan="2"></td><td colspan="2">Splenic aspirate parasitologic result</td><td rowspan="2">Total</td></tr><tr><td>Negative</td><td>Positive</td></tr><tr><td>Positive</td><td>13</td><td>37</td><td>50</td></tr><tr><td>Total</td><td>18</td><td>44</td><td>62</td></tr></table> |
aff02633178c7209b4098ffae0ed9e22300a30502e7f927668c87351fca8d57a.png | complex | <table><tr><td></td><td colspan="3"># of Patients (%)</td></tr><tr><td>Characteristic</td><td>Female</td><td>Male</td><td>P Value</td></tr><tr><td>Age (yrs) (n = 86)</td><td></td><td></td><td>0.26</td></tr><tr><td> <60</td><td>37 (88.1%)</td><td>42 (95.5%)</td><td></td></tr><tr><td> >/=60</td><td>5 (11.9%)</td><t... | <table><tr><td></td><td colspan="3"># of Patients (%)</td></tr><tr><td>Characteristic</td><td>Female</td><td>Male</td><td>P Value</td></tr><tr><td>Age (yrs) (n = 86)</td><td></td><td></td><td>0.26</td></tr><tr><td><60</td><td>37 (88.1%)</td><td>42 (95.5%)</td><td></td></tr><tr><td>>/=60</td><td>5 (11.9%)</td><td>2 (4.5... | <table><tr><td></td><td colspan="3"># of Patients (%)</td></tr><tr><td>Characteristic</td><td>Female</td><td>Male</td><td>P Value</td></tr><tr><td>(n = 64)</td><td></td><td></td><td></td></tr><tr><td></=780 low-risk</td><td>19 (52.8%)</td><td>16 (57.1%)</td><td></td></tr><tr><td>>780 and </=1480 intermediate</td><td>12... |
be62be40b467a787aff53d60f51c6e8c2a1f836cb8463054b34e085375d11b21.png | simple | <table><tr><td> </td><td>Category</td><td>No. of cases</td><td>Meandensity of TFPI-2 Mean± SD</td><td>Statistics value</td><td>p value</td></tr><tr><td>Age</td><td>≤55</td><td>74</td><td>0.324±0.061</td><td>t=0.302</td><td>0.764</td></tr><tr><td> </td><td>>55</td><td>47</td><td>0.327±0.052</td><... | <table><tr><td></td><td>Category</td><td>No. of cases</td><td>Meandensity of TFPI-2 Mean± SD</td><td>Statistics value</td><td>p value</td></tr><tr><td>Age</td><td>≤55</td><td>74</td><td>0.324±0.061</td><td>t=0.302</td><td>0.764</td></tr><tr><td></td><td>>55</td><td>47</td><td>0.327±0.052</td><td></td><td></td></tr><tr>... | <table><tr><td></td><td>4-9</td><td>15</td><td>0.316±0.048</td><td></td><td></td></tr><tr><td></td><td>10-</td><td>13</td><td>0.272±0.038</td><td></td><td></td></tr><tr><td></td><td>Unknown</td><td>1</td><td></td><td></td><td></td></tr><tr><td>Histologic grade</td><td>≤II</td><td>71</td><td>0.339±0.057</td><td>t=3.389<... |
c2763945454fa5fb18de7a1ffd8bda3a5ea38bd153b15d199573281eeedade06.png | complex | <table><tr><td rowspan="2"><i>var</i> gene type<sup>a</sup></td><td rowspan="2">Genome</td><td rowspan="2">Geographic origin</td><td colspan="2">Binding phenotype</td><td colspan="2">No. of potential thrombin cleavage sites by<sup>b</sup>:</td><td colspan="2">No. of potential thrombin cleavage sites with sequence<sup>b... | <table><tr><td rowspan="2">var gene typea</td><td rowspan="2">Genome</td><td rowspan="2">Geographic origin</td><td>Binding phenotype</td></tr><tr><td>CIDR1</td></tr><tr><td>IT4var06 (DC8)</td><td>IT4/FCR3</td><td>Southeast Asia</td><td>EPCR</td></tr><tr><td>IT4var19 (DC8)</td><td>IT4/FCR3</td><td>Southeast Asia</td><td... | <table><tr><td>Binding phenotype</td><td colspan="2">No. of potential thrombin cleavage sites byb:</td><td colspan="2">No. of potential thrombin cleavage sites with sequenceb:</td><td colspan="3">Presence ofc:</td><td rowspan="2">Thrombin cleavage</td></tr><tr><td>Other</td><td>Prosper</td><td>Peptide Cutter</td><td>PR... |
0f78daccc25112d57bf10499fada2c90f64e891bd2077ed73a1eb495ce389345.png | simple | <table><tr><td>Reference material (Certified or recommended values)</td><td>Matrix</td><td>Recovery rate</td></tr><tr><td>NIST 1643e (60.45±0.72 ppb)</td><td>Water</td><td>93 to 102%</td></tr><tr><td>NIST 1568a (290±30 ppb)</td><td>Poultry feed/Excreta</td><td>91 to 99%</td></tr><tr><td>Arsenic standard (20 p... | <table><tr><td>Reference material (Certified or recommended values)</td><td>Matrix</td><td>Recovery rate</td></tr><tr><td>NIST 1643e (60.45±0.72 ppb)</td><td>Water</td><td>93 to 102%</td></tr></table> | <table><tr><td>Reference material (Certified or recommended values)</td><td>Matrix</td><td>Recovery rate</td></tr><tr><td>NIST 1568a (290±30 ppb)</td><td>Poultry feed/Excreta</td><td>91 to 99%</td></tr><tr><td>Arsenic standard (20 ppb)</td><td>Egg</td><td>89 to 97%</td></tr></table> |
a02e16f90426187d41f8399979d622b2648094be5b9bafbb8fd03b20f614f579.png | simple | <table><tr><td> </td><td>Conventional group</td><td>Cocktail group</td><td>P</td></tr><tr><td>Mean dosage (mg) <sup>a</sup></td><td> </td><td> </td><td>N/A</td></tr><tr><td>- Meperidine</td><td>58.33 ± 24.46</td><td>25</td><td> </td></tr><tr><td>- Midazolam</td><td>6.81 ± 2.12</td><td>2.5</td><td> </td></tr><... | <table><tr><td></td><td>Conventional group</td></tr><tr><td>Mean dosage (mg) a</td><td></td></tr><tr><td>- Meperidine</td><td>58.33 ± 24.46</td></tr><tr><td>- Midazolam</td><td>6.81 ± 2.12</td></tr><tr><td>- Propofol</td><td>0</td></tr><tr><td>Dosage (mg/kg/hr) a</td><td></td></tr><tr><td>- Meperidine</td><td>2.42 ± 2.... | <table><tr><td>Cocktail group</td><td>P</td></tr><tr><td></td><td>N/A</td></tr><tr><td>25</td><td></td></tr><tr><td>2.5</td><td></td></tr><tr><td>172.08 ± 92.15</td><td></td></tr><tr><td></td><td>N/A</td></tr><tr><td>1.06 ± 0.60</td><td></td></tr><tr><td>0.11 ± 0.06</td><td></td></tr><tr><td>6.18 ± 3.0</td><td></td></t... |
8644c67fab9a905794708e172bb46195ee0f72145d3bcddf39f0db9f4d53ec66.png | simple | <table><tr><td>Construct</td><td>[NaCl]</td><td><i>K<sub>d</sub></i></td></tr><tr><td></td><td><i>mm</i></td><td><i>nm</i></td></tr><tr><td>N-domain</td><td>0</td><td>47.80 ± 4.94</td></tr><tr><td></td><td>20</td><td>4.61 ± 0.63</td></tr><tr><td>C-domain</td><td>0</td><td>45.50 ± 4.24</td></tr><tr><td></... | <table><tr><td>Construct</td><td>[NaCl]</td></tr><tr><td></td><td>mm</td></tr><tr><td>N-domain</td><td>0</td></tr><tr><td></td><td>20</td></tr><tr><td>C-domain</td><td>0</td></tr><tr><td></td><td>20</td></tr><tr><td>R186H</td><td>0</td></tr><tr><td></td><td>20</td></tr><tr><td>E403R</td><td>0</td></tr><tr><td></td><td>... | <table><tr><td>Kd</td></tr><tr><td>nm</td></tr><tr><td>47.80 ± 4.94</td></tr><tr><td>4.61 ± 0.63</td></tr><tr><td>45.50 ± 4.24</td></tr><tr><td>13.50 ± 2.06</td></tr><tr><td>132.00 ± 6.72</td></tr><tr><td>4.42 ± 0.50</td></tr><tr><td>2.67 ± 0.31</td></tr><tr><td>6.76 ± 0.65</td></tr><tr><td>22.00 ± 3.31</td></tr><tr><t... |
2e3dece24f093342b704fafbb2134ddedd81e7d2db105473786fe708118dad2a.png | simple | <table><tr><td>Characteristics</td><td>Whole cohort (<i>n</i> = 5685)</td></tr><tr><td>Women (%)</td><td>2782 (50.6)</td></tr><tr><td>Age (years)</td><td>43.7 ± 0.4</td></tr><tr><td>Race/ethnicity (%)</td><td></td></tr><tr><td> Non-Hispanic whites</td><td>2898 (73.5)</td></tr><tr><td> Non-Hispanic blacks</td><td>1... | <table><tr><td>Characteristics</td><td>Whole cohort (n = 5685)</td></tr><tr><td>Women (%)</td><td>2782 (50.6)</td></tr></table> | <table><tr><td>Age (years)</td><td>43.7 ± 0.4</td></tr><tr><td>Race/ethnicity (%)</td><td></td></tr><tr><td>Non-Hispanic whites</td><td>2898 (73.5)</td></tr><tr><td>Non-Hispanic blacks</td><td>1085 (9.4)</td></tr><tr><td>Mexican Americans</td><td>1021 (7.8)</td></tr><tr><td>Others</td><td>681 (9.3)</td></tr><tr><td>Edu... |
7d780019bcf95929e588f51bcb8ef10914d0aaf2c477b645116ef2f46a8411ef.png | simple | <table><tr><td><i>In vitro</i></td><td>Percentage of CD4<sup>+</sup>IL-10<sup>+</sup> (%)</td><td>MFI CD4<sup>+</sup>IL-10<sup>+</sup></td><td>iMFI CD4<sup>+</sup>IL-10<sup>+</sup></td></tr><tr><td>BALB/c</td><td>14·2 ± 1·2</td><td>125·0 ± 11·2</td><td>1775·0 ± 121·9</td></t... | <table><tr><td>In vitro</td><td>Percentage of CD4+IL-10+ (%)</td><td>MFI CD4+IL-10+</td><td>iMFI CD4+IL-10+</td></tr><tr><td>BALB/c</td><td>14·2 ± 1·2</td><td>125·0 ± 11·2</td><td>1775·0 ± 121·9</td></tr></table> | <table><tr><td>In vitro</td><td>Percentage of CD4+IL-10+ (%)</td><td>MFI CD4+IL-10+</td><td>iMFI CD4+IL-10+</td></tr><tr><td>CBA</td><td>3·3 ± 0·2</td><td>82·1 ± 4·6</td><td>270·9 ± 15·6</td></tr></table> |
dd8bfce64fd29fc5fa843b08fc9b8b583192d4c0a85c4c41869671559c07e2b9.png | complex | <table><tr><td>Name</td><td>Forward and Revers Primers</td><td>Product Size</td><td>Comment</td></tr><tr><td rowspan="2">Bo 5S IGS</td><td>F: ACTAGGATGGGTGACCTCCCG;</td><td rowspan="2">484</td><td rowspan="2">5S-IGS product size</td></tr><tr><td>R: CGCTTAACTGCGGAGTTCTGA</td></tr><tr><td rowspan="2">Bo ITS1 and 2</td><t... | <table><tr><td>Name</td><td>Forward and Revers Primers</td><td>Product Size</td><td>Comment</td></tr><tr><td rowspan="2">Bo 5S IGS</td><td>F: ACTAGGATGGGTGACCTCCCG;</td><td rowspan="2">484</td><td rowspan="2">5S-IGS product size</td></tr><tr><td>R: CGCTTAACTGCGGAGTTCTGA</td></tr><tr><td rowspan="2">Bo ITS1 and 2</td><t... | <table><tr><td>Bo 45S IGS</td><td>R: ATGACTACTGGCAGGATCAACCAG</td><td>variable</td><td>45S-IGS product size</td></tr><tr><td>IGS inter-D</td><td>ATCGTGTAGGACCGAGAAGT</td><td></td><td>D type intergenic</td></tr><tr><td>IGS inter-CEF</td><td>GGTAGGCACAAAAGGAATGC</td><td></td><td>C, E and F type intergenic</td></tr></tabl... |
dcede713f94629a2fa5783ee9066f1293797cbbfac179852069de429ea54c2db.png | complex | <table><tr><td>Variable of Interest</td><td></td><td><i>n</i></td><td>Mean</td><td>Standard Deviation</td><td>Notes</td></tr><tr><td>Age (years)</td><td></td><td>344</td><td>61.8</td><td>7.6</td><td></td></tr><tr><td>Age of menarche (years)</td><td></td><td>335</td><td>13.3</td><td>1.7</td><td>9 could not recall the ag... | <table><tr><td>Variable of Interest</td><td></td><td>n</td><td>Mean</td><td>Standard Deviation</td><td>Notes</td></tr><tr><td>Age (years)</td><td></td><td>344</td><td>61.8</td><td>7.6</td><td></td></tr><tr><td>Age of menarche (years)</td><td></td><td>335</td><td>13.3</td><td>1.7</td><td>9 could not recall the age of me... | <table><tr><td rowspan="2">Cigarette smoking status</td><td>Current smoker</td><td>8</td><td>2.3</td><td></td><td></td></tr><tr><td>Ex-smoker</td><td>1</td><td>0.3</td><td></td><td></td></tr><tr><td rowspan="3">Alcohol drinking</td><td>Non-drinker</td><td>336</td><td>97.7</td><td></td><td></td></tr><tr><td>Current drin... |
c7bdd8ee1a3becb23807364cbdf8ea3b1b7b5543161329a4040f03c55721887a.png | complex | <table><tr><td>SPARQL Query</td><td>Note</td></tr><tr><td>SELECT DISTINCT ?label ?definitionContent ?ontologyId ?termId</td><td rowspan="9">To extract the definition and its metadata for a specific ICD category, A19 – Miliary tuberculosis</td></tr><tr><td> { GRAPH <http://who.int/icd></td></tr><tr><td>{ <... | <table><tr><td>SPARQL Query</td><td>Note</td></tr><tr><td>SELECT DISTINCT ?label ?definitionContent ?ontologyId ?termId</td><td rowspan="6">To extract the definition and its metadata for a specific ICD category, A19 – Miliary tuberculosis</td></tr><tr><td>{ GRAPH <http://who.int/icd></td></tr><tr><td>{ <http://who.int/... | <table><tr><td>SPARQL Query</td><td>Note</td></tr><tr><td><http://who.int/icd#termId> ?termId;</td><td rowspan="3">To extract the definition and its metadata for a specific ICD category, A19 – Miliary tuberculosis</td></tr><tr><td></td></tr><tr><td>}}</td></tr></table> |
d7c27bc493f1cebc485a073d3a1914de6edab2eb6707e80103d6ba03c74c55d3.png | simple | <table><tr><td>Disease</td><td>Protein Defect</td><td>iNKT Cells</td><td>Type II NKT Cells</td><td>iNKT Cell Subsets</td></tr><tr><td>Gaucher</td><td>β-glucosidase (Glucocerebrosidase)</td><td>= [13]</td><td>↑ (glucosylsphingosine-specific) [13]</td><td>ND</td></tr><tr><td>Fabry</td><td>α-galactosidase ... | <table><tr><td>Disease</td></tr><tr><td>Gaucher</td></tr><tr><td>Fabry</td></tr><tr><td>NPC</td></tr></table> | <table><tr><td>Protein Defect</td><td>iNKT Cells</td><td>Type II NKT Cells</td><td>iNKT Cell Subsets</td></tr><tr><td>β-glucosidase (Glucocerebrosidase)</td><td>= [13]</td><td>↑ (glucosylsphingosine-specific) [13]</td><td>ND</td></tr><tr><td>α-galactosidase A</td><td>= [71]</td><td>ND</td><td>↓ CD4+ iNKT cells [71]</td... |
7e1c67017510f4688c94a4ad8ff00969c26ab71cf26d4515aa7c83803006525a.png | simple | <table><tr><td>Collection Round</td><td>eHSR Trap Nights <sup>1</sup></td><td><i>Culex</i> spp. Ehsr <sup>1</sup></td><td><i>Culex</i> spp. Abundance Trap Nights <sup>2</sup></td><td><i>Culex</i> spp. Abundance <sup>2</sup></td><td>Nestlings</td><td>Culex: Nestlings</td><td>IR <sup>3</sup></td></tr><tr><td>1–15 J... | <table><tr><td>Collection Round</td><td>eHSR Trap Nights 1</td><td>Culex spp. Ehsr 1</td><td>Culex spp. Abundance Trap Nights 2</td><td>Culex spp. Abundance 2</td><td>Nestlings</td></tr><tr><td>1–15 June</td><td>43</td><td>0.4 ± 0.26</td><td>161</td><td>9.9 ± 1.09</td><td>107.2 ± 2.06</td></tr><tr><td>16–30 June</td><t... | <table><tr><td>Culex: Nestlings</td><td>IR 3</td></tr><tr><td>0.09</td><td>1.9</td></tr><tr><td>0.1</td><td>0</td></tr><tr><td>0.22</td><td>0</td></tr><tr><td>0.27</td><td>1.7</td></tr><tr><td>0.47</td><td>7.9</td></tr><tr><td>4.15</td><td>2.1</td></tr></table> |
589e86f482c64476ea31cc02bff20611292b424150ed5a749366afec593005da.png | complex | <table><tr><td rowspan="2">Covariate</td><td colspan="2"><i>P </i>value</td><td colspan="2">Hazard radio</td><td colspan="2">95% Confidence interval</td></tr><tr><td>Univariate</td><td>Added SBEM</td><td>Univariate</td><td>Added SBEM</td><td>Univariate</td><td>Added SBEM</td></tr><tr><td>SBEM (3+ <i>vs.</i> <3+)</td... | <table><tr><td>Covariate</td><td colspan="2">P value</td><td colspan="2">Hazard radio</td><td colspan="2">95% Confidence interval</td></tr></table> | <table><tr><td>Covariate</td><td>Univariate</td><td>Added SBEM</td><td>Univariate</td><td>Added SBEM</td><td>Univariate</td><td>Added SBEM</td></tr><tr><td>SBEM (3+ vs. <3+)</td><td>0.000</td><td>0.000</td><td>4.113</td><td>4.113</td><td>2.004-8.440</td><td>2.004-8.440</td></tr><tr><td>Lymph Node (Pos. vs. Neg.)</td><t... |
471fa526b9ecda9389b2e1d39ab8ab0f051af42025e5227b48b0a67c97c1aa5c.png | simple | <table><tr><td>Properties</td><td>Rejuvenator A</td><td>Rejuvenator B</td><td>Test Method</td></tr><tr><td>Form</td><td>Liquid</td><td>Liquid</td><td></td></tr><tr><td>Color</td><td>pink</td><td>Brown</td><td></td></tr><tr><td>pH</td><td>4.8</td><td>5.6</td><td>pH test paper</td></tr><tr><td>Viscosity (25 °C), SFS... | <table><tr><td>Properties</td><td>Rejuvenator A</td><td>Rejuvenator B</td><td>Test Method</td></tr><tr><td>Form</td><td>Liquid</td><td>Liquid</td><td></td></tr><tr><td>Color</td><td>pink</td><td>Brown</td><td></td></tr><tr><td>pH</td><td>4.8</td><td>5.6</td><td>pH test paper</td></tr></table> | <table><tr><td>Viscosity (25 °C), SFS</td><td>40</td><td>15</td><td>ASTM D-244</td></tr><tr><td>Solute component [wt %]</td><td>65</td><td>60</td><td>ASTM D-244</td></tr><tr><td>Regeneration component [wt %]</td><td>8</td><td>8</td><td>ASTM D-2006-70</td></tr><tr><td>Asphaltene component [wt %]</td><td>0.4</td><td>0.75... |
d3ba3e63838282f394bbb7abe82d537ec359667a50f918a79b1cbe9e7cc0a677.png | complex | <table><tr><td rowspan="2">CT and MRI Metrics</td><td colspan="2">ILD</td><td colspan="2">Non ILD</td></tr><tr><td>AUC</td><td><i>p</i> value</td><td>AUC</td><td><i>p</i> value</td></tr><tr><td colspan="5">CT</td></tr><tr><td>Main PA Diameter</td><td>0.873</td><td><0.001</td><td>0.835</td><td><0.001</td></tr><tr>... | <table><tr><td rowspan="2">CT and MRI Metrics</td><td colspan="2">ILD</td><td colspan="2">Non ILD</td></tr><tr><td>AUC</td><td>p value</td><td>AUC</td><td>p value</td></tr><tr><td colspan="5">CT</td></tr><tr><td>Main PA Diameter</td><td>0.873</td><td><0.001</td><td>0.835</td><td><0.001</td></tr><tr><td>PA/AA</td><td>0.... | <table><tr><td rowspan="2">CT and MRI Metrics</td><td colspan="2">ILD</td><td colspan="2">Non ILD</td></tr><tr><td>AUC</td><td>p value</td><td>AUC</td><td>p value</td></tr><tr><td>Right PA Diameter</td><td>0.753</td><td>0.012</td><td>0.757</td><td><0.001</td></tr><tr><td>Left PA Diameter</td><td>0.729</td><td>0.023</td... |
e7ea69945160cd921c669c945ad2816efb06f0232288ae195233bfc4aed642f6.png | simple | <table><tr><td></td><td>ME II</td><td>NFE II</td><td><i>P</i> Value</td><td>RR (95% confidence interval)</td></tr><tr><td>Prior admissions</td><td>19/23 (83%)</td><td>22/25 (88%)</td><td>NS</td><td></td></tr><tr><td>Prior intubation</td><td>9/30 (30%)</td><td>16/27 (59%)</td><td>0.03</td><td>1.97 (1–3.7)</td></tr... | <table><tr><td></td><td>ME II</td><td>NFE II</td><td>P Value</td><td>RR (95% confidence interval)</td></tr><tr><td>Prior admissions</td><td>19/23 (83%)</td><td>22/25 (88%)</td><td>NS</td><td></td></tr><tr><td>Prior intubation</td><td>9/30 (30%)</td><td>16/27 (59%)</td><td>0.03</td><td>1.97 (1–3.7)</td></tr><tr><td>B2 a... | <table><tr><td></td><td>ME II</td><td>NFE II</td><td>P Value</td></tr><tr><td>FiO2 (%)</td><td>40 ± 21(19)</td><td>71 ± 32(26)</td><td>0.001</td></tr><tr><td>A-aO2 (mmHg)</td><td>136 ± 128(19)</td><td>188 ± 142(26)</td><td>0.09</td></tr><tr><td>WBC (mm3)</td><td>11,500 ± 4,000(29)</td><td>15,600 ± 6,200(25)</td><td>0.0... |
e918fd9a16c202c94b8415aef10a3bed7eef7e5fbe75667a37447ce8c57c6250.png | simple | <table><tr><td>Phage density</td><td>Bacterial density</td><td>Implication</td></tr><tr><td>High</td><td>High</td><td>Low adsorption rate or partial bacterial refuge, poor control of bacteria. Gives insight to failure</td></tr><tr><td>High</td><td>Low</td><td>Not sustainable – a possible transitory step following... | <table><tr><td>Phage density</td><td>Bacterial density</td><td>Implication</td></tr></table> | <table><tr><td>High</td><td>High</td><td>Low adsorption rate or partial bacterial refuge, poor control of bacteria. Gives insight to failure</td></tr><tr><td>High</td><td>Low</td><td>Not sustainable – a possible transitory step following successful control of bacteria, before phage densities have equilibrated</td></tr>... |
bd39cf2c632d5cfaa0a2f329a28cfaeddca155c7215e1afd0f210f7b3979a575.png | complex | <table><tr><td> </td><td colspan="2">Sango and Daiya</td><td> </td></tr><tr><td> </td><td>Within reach</td><td>Out of reach</td><td>χ<sup>2</sup>(1)</td></tr><tr><td>Robin and Daiya</td><td> </td><td> </td><td> </td></tr><tr><td>Within reach</td><td>32</td><td>62</td><td>0.92</td></tr><tr><td>Out of reach</td><td>... | <table><tr><td></td><td>Sango and Daiya</td></tr><tr><td></td><td>Within reach</td></tr><tr><td>Robin and Daiya</td><td></td></tr><tr><td>Within reach</td><td>32</td></tr><tr><td>Out of reach</td><td>114</td></tr><tr><td>Koyuki and Daiya</td><td></td></tr><tr><td>Within reach</td><td>32</td></tr><tr><td>Out of reach</t... | <table><tr><td>Sango and Daiya</td><td></td></tr><tr><td>Out of reach</td><td>χ2(1)</td></tr><tr><td></td><td></td></tr><tr><td>62</td><td>0.92</td></tr><tr><td>174</td><td></td></tr><tr><td></td><td></td></tr><tr><td>30</td><td>6.12*</td></tr><tr><td>189</td><td></td></tr><tr><td></td><td></td></tr><tr><td>26</td><td>... |
9b18d26a2a5d37dba6f45f297dd8189023ba65078c722d07600c15801483d2d5.png | complex | <table><tr><td></td><td colspan="4">Proportion of recurrence</td><td colspan="4">Proportion of death</td></tr><tr><td></td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td></tr><tr><td>Group 1</td><td>-</td><td>0.175</td><td><0.0001</td><... | <table><tr><td></td><td colspan="4">Proportion of recurrence</td><td colspan="4">Proportion of death</td></tr><tr><td></td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td></tr><tr><td>Group 1</td><td>-</td><td>0.175</td><td><0.0001</td><td>... | <table><tr><td></td><td colspan="4">Proportion of recurrence</td><td colspan="4">Proportion of death</td></tr><tr><td></td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td></tr><tr><td>oup 3</td><td>-</td><td>-</td><td>-</td><td>0.080</td><t... |
6f1ab71bab9df4b227ade27db463108547754c89e3f92f04cdc83a298ad4729d.png | complex | <table><tr><td rowspan="2">Scale</td><td colspan="4">Cronbach’s alpha</td></tr><tr><td>Male</td><td>Female</td><td>Single</td><td>Married</td></tr><tr><td>Energy</td><td>0.87</td><td>0.87</td><td>0.76</td><td>0.81</td></tr><tr><td>Family role</td><td>0.77</td><td>0.72</td><td>0.39</td><td>0.79</td></tr><tr><td>La... | <table><tr><td rowspan="2">Scale</td><td colspan="4">Cronbach’s alpha</td></tr><tr><td>Male</td><td>Female</td><td>Single</td><td>Married</td></tr><tr><td>Energy</td><td>0.87</td><td>0.87</td><td>0.76</td><td>0.81</td></tr><tr><td>Family role</td><td>0.77</td><td>0.72</td><td>0.39</td><td>0.79</td></tr><tr><td>Language... | <table><tr><td rowspan="2">Scale</td><td colspan="4">Cronbach’s alpha</td></tr><tr><td>Male</td><td>Female</td><td>Single</td><td>Married</td></tr><tr><td>le</td><td>90</td><td>0.84</td><td>0.85</td><td>.89</td></tr><tr><td>Thinking</td><td>0.80</td><td>0.83</td><td>0.90</td><td>0.79</td></tr><tr><td>Mood</td><td>0.82<... |
1096e25b8c724ec7d50d766cc22fe227dbc01ccd50e6bf88e25f3cf1a7e6f6fe.png | simple | <table><tr><td>Bands analyzed</td><td>Proteins detected</td><td>Database accession number</td><td>MOWSE score</td><td>Number of unique peptide identified</td><td>Sequence coverage, %</td><td>emPAI value</td></tr><tr><td>1</td><td>HoxF NAD-reducing hydrogenase diaphorase moiety large subunit [<i>R. eutropha</i> H16]</td... | <table><tr><td>Bands analyzed</td><td>Proteins detected</td><td>Database accession number</td><td>MOWSE score</td><td>Number of unique peptide identified</td><td>Sequence coverage, %</td><td>emPAI value</td></tr></table> | <table><tr><td>1</td><td>HoxF NAD-reducing hydrogenase diaphorase moiety large subunit [R. eutropha H16]</td><td>gi|38637753</td><td>4562</td><td>142</td><td>81</td><td>61.43</td></tr><tr><td>2</td><td>HoxH NAD-reducing hydrogenase moiety large subunit [R. eutropha H16]</td><td>gi|38637756</td><td>3401</td><td>112</td>... |
602dd1f4a5cba9119410901632cceb045914c3e280bcb51084292dbfd7062b4b.png | simple | <table><tr><td>Study Outcome and Factors</td><td>2 Years <i>n</i> (%)</td><td>3.5 Years <i>n</i> (%)</td><td><i>p</i></td></tr><tr><td>Child outdoor playtime</td><td></td><td></td><td>0.126</td></tr><tr><td> <2 h/day</td><td>181 (37)</td><td>135 (33)</td><td></td></tr><tr><td> ≥2 h/day</td><td>305 (63)</td><td... | <table><tr><td>Study Outcome and Factors</td><td>2 Years n (%)</td><td>3.5 Years n (%)</td><td>p</td></tr><tr><td>Child outdoor playtime</td><td></td><td></td><td>0.126</td></tr><tr><td><2 h/day</td><td>181 (37)</td><td>135 (33)</td><td></td></tr><tr><td>≥2 h/day</td><td>305 (63)</td><td>379 (67)</td><td></td></tr><tr>... | <table><tr><td>Study Outcome and Factors</td><td>2 Years n (%)</td><td>3.5 Years n (%)</td><td>p</td></tr><tr><td>>50 (walkable)</td><td>195 (45)</td><td>149 (43)</td><td></td></tr><tr><td>Population density</td><td></td><td></td><td>0.135</td></tr><tr><td><18/hatch (mean)</td><td>232 (50)</td><td>204 (55)</td><td></td... |
39bd3c9471f84cb904bdba5df35a9390ed04556451367999f8d4d4c0e4959f57.png | complex | <table><tr><td>Subcategories of DRPs</td><td>Number of DRPs</td><td>%</td><td>resolved</td></tr><tr><td colspan="4">Doctors (N = 272)</td></tr><tr><td> Unnecessary therapy/No clinical indication</td><td>13</td><td>92.3%</td><td>(12/13)</td></tr><tr><td> Untreated indication</td><td>162</td><td>71.6%</td><td>(116/162)</... | <table><tr><td>Subcategories of DRPs</td><td>Number of DRPs</td><td>%</td><td>resolved</td></tr><tr><td colspan="4">Doctors (N = 272)</td></tr><tr><td>Unnecessary therapy/No clinical indication</td><td>13</td><td>92.3%</td><td>(12/13)</td></tr><tr><td>Untreated indication</td><td>162</td><td>71.6%</td><td>(116/162)</td... | <table><tr><td>Subcategories of DRPs</td><td>Number of DRPs</td><td>%</td><td>resolved</td></tr><tr><td>Charting error</td><td>2</td><td>100.0%</td><td>(2/2)</td></tr></table> |
dbf162d183ad110487e65d56159d2dcbbb7ad3d65c5870aa468967ea854ffac9.png | complex | <table><tr><td></td><td colspan="4">Group V</td><td colspan="4">Group I</td></tr><tr><td></td><td>UAI</td><td></td><td>Univariate</td><td>Multivariate OR</td><td>UAI</td><td></td><td>Univariate</td><td>Multivariate OR</td></tr><tr><td></td><td>Row%</td><td>(n)</td><td>OR</td><td>(95%CI)</td><td>Row%</td><td>(n)</td><td... | <table><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Socio-demographics</td></tr><tr><td>Age groups</td></tr><tr><td>18-29</td></tr><tr><td>≥30</td></tr><tr><td>Number of items showing perceived discrimination against MSM (to the above 3 items)</td></tr><tr><td>0 - 2 discrimination responses</td></tr><t... | <table><tr><td colspan="4">Group V</td><td colspan="4">Group I</td></tr><tr><td>UAI</td><td></td><td>Univariate</td><td>Multivariate OR</td><td>UAI</td><td></td><td>Univariate</td><td>Multivariate OR</td></tr><tr><td>Row%</td><td>(n)</td><td>OR</td><td>(95%CI)</td><td>Row%</td><td>(n)</td><td>OR</td><td>(95%CI)</td></t... |
3b865c95c4928b0683aa6e47d0b3625b8356f6e94c676f505b6df49724b56a1b.png | complex | <table><tr><td rowspan="2">Features</td><td><sup>1</sup>pSS Abs<sup>−</sup></td><td><sup>2</sup>pSS Abs<sup>+</sup></td><td><i>P</i><sup>*</sup></td></tr><tr><td>(<i>n</i> = 29)</td><td>(<i>n</i> = 23)</td><td>I-II</td></tr><tr><td>Age, mean ± SD years</td><td>56 ± 12</td><td>56 ± 13 </td><td>0.873... | <table><tr><td>Features</td><td>1pSS Abs−</td><td>2pSS Abs+</td><td>P*</td></tr></table> | <table><tr><td>Features</td><td>(n = 29)</td><td>(n = 23)</td><td>I-II</td></tr><tr><td>Age, mean ± SD years</td><td>56 ± 12</td><td>56 ± 13</td><td>0.873</td></tr><tr><td>Schirmer's I test (mm/5 min), mean ± SD</td><td>3.17 ± 1.20</td><td>1.25 ± 1.12</td><td><0.0001</td></tr><tr><td>Unstimulated salivary flow (mL/15 m... |
3b74ec3f61edd5df0d13892404ffdc426c960b16264a16d4e1f2b429ca54a563.png | simple | <table><tr><td>Compared organisms</td><td>CCMP1545</td><td>CCMP1545</td><td>RCC299</td><td>CCMP1545</td><td><i>O. lucimarinus</i></td></tr><tr><td>(pairs)</td><td>RCC299</td><td>CCMP2099</td><td>CCMP2099</td><td><i>O. lucimarinus</i></td><td><i>O</i>. RCC809</td></tr><tr><td>ID (%)</td><td>60</td><td>57</td><td>57</td>... | <table><tr><td>Compared organisms</td><td>CCMP1545</td><td>CCMP1545</td><td>RCC299</td><td>CCMP1545</td><td>O. lucimarinus</td></tr><tr><td>(pairs)</td><td>RCC299</td><td>CCMP2099</td><td>CCMP2099</td><td>O. lucimarinus</td><td>O. RCC809</td></tr></table> | <table><tr><td>Compared organisms</td><td>CCMP1545</td><td>CCMP1545</td><td>RCC299</td><td>CCMP1545</td><td>O. lucimarinus</td></tr><tr><td>ID (%)</td><td>60</td><td>57</td><td>57</td><td>54</td><td>73</td></tr><tr><td>Coverage (%)</td><td>78</td><td>74</td><td>77</td><td>83</td><td>93</td></tr><tr><td>Gene fraction (%... |
9200e9b9169dbc44633b0275b1729cccdf085c5d3e76f77abacd06b924c4cf46.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">Hbase and Phoenix</td><td colspan="4">Cassandra and Presto</td></tr><tr><td>Query 1</td><td>Query 2</td><td>Query 3</td><td>Query 4</td><td>Query 1</td><td>Query 2</td><td>Query 3</td><td>Query 4</td></tr><tr><td>3 nodes processing speed (s)</td><td>48.5</td><td>2.32</td>... | <table><tr><td rowspan="2"></td><td colspan="4">Hbase and Phoenix</td><td colspan="4">Cassandra and Presto</td></tr><tr><td>Query</td><td>Query</td><td>Quer</td><td></td><td>Que</td><td>Query 2</td><td>Query </td><td>Query 4</td></tr></table> | <table><tr><td></td><td> 1</td><td> 2</td><td>y 3</td><td>Query 4</td><td>ry 1</td><td></td><td>3</td><td></td></tr><tr><td>3 nodes processing speed (s)</td><td>48.5</td><td>2.32</td><td>80.2</td><td>78.5</td><td>40.1</td><td>2</td><td>25</td><td>13</td></tr><tr><td>5 nodes processing speed (s)</td><td>27.9</td><td>1.7... |
e86f78d38114db8cc7cc1c1626d2dfbc608d41b82ea483fdf628648ae9e9d827.png | complex | <table><tr><td>EDAD</td><td colspan="2">♂</td><td colspan="2">♀</td><td></td><td colspan="2">♀♂</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>♀/♂ </td><td>N</td><td>%</td></tr><tr><td>< 20</td><td>3</td><td>50.00</td><td>3</td><td>50.00</td><td>1.00</td><td>6</... | <table><tr><td>EDAD</td><td colspan="2">♂</td></tr><tr><td></td><td>N</td><td>%</td></tr><tr><td>< 20</td><td>3</td><td>50.00</td></tr><tr><td>20.1 - 30</td><td>4</td><td>33.33</td></tr><tr><td>30.1 - 40</td><td>9</td><td>32.14</td></tr><tr><td>40.1 - 50</td><td>20</td><td>28.17</td></tr><tr><td>50.1 - 60</td><td>20</t... | <table><tr><td colspan="2">♀</td><td></td><td colspan="2">♀♂</td></tr><tr><td>N</td><td>%</td><td>♀/♂</td><td>N</td><td>%</td></tr><tr><td>3</td><td>50.00</td><td>1.00</td><td>6</td><td>2.46</td></tr><tr><td>8</td><td>66.67</td><td>2.00</td><td>12</td><td>4.92</td></tr><tr><td>19</td><td>67.86</td><td>2.10</td><td>28</... |
40084f8d5d9f1bea4f7f87e34613394e5100e82dc5ae9d867b33213853ff5274.png | complex | <table><tr><td rowspan="2">Pellet</td><td rowspan="2">kVp</td><td rowspan="2">mAs</td><td rowspan="2">Filter</td><td rowspan="2">iDose<sup>4</sup> level</td><td>No MoM THA baseline</td><td>MoM THA O-MAR off</td><td>MoM THA O-MAR on</td></tr><tr><td>CNR</td><td>CNR</td><td>CNR</td></tr><tr><td>L0</td><td>120</td><td>150... | <table><tr><td rowspan="2">Pellet</td><td rowspan="2">kVp</td><td rowspan="2">mAs</td><td rowspan="2">Filter</td><td rowspan="2">iDose4 level</td><td>No MoM THA baseline</td><td>MoM THA O-MAR off</td><td>MoM THA O-MAR on</td></tr><tr><td>CNR</td><td>CNR</td><td>CNR</td></tr><tr><td>L0</td><td>120</td><td>150</td><td>A<... | <table><tr><td>L8</td><td>120</td><td>150</td><td>A</td><td>5</td><td>23.12</td><td>5.18</td><td>4.19</td></tr><tr><td>L0</td><td>120</td><td>600</td><td>A</td><td>5</td><td>46.52</td><td>23.07</td><td>23.07</td></tr><tr><td>L5</td><td>120</td><td>600</td><td>A</td><td>5</td><td>41.18</td><td>26.31</td><td>37.11</td></... |
19ed0c09f1c3b569da775c47bcc94cfac15d5e841e7511c0a6a42a2239c859af.png | simple | <table><tr><td>Comparison</td><td>Pearson’s Correlation coefficient</td><td>R-squared value</td></tr><tr><td>NBME (raw) version V1 EM M4</td><td>0.51</td><td>0.26</td></tr><tr><td>NBME (scaled) version V1 EM M4</td><td>0.42</td><td>0.18</td></tr><tr><td>NBME (raw) version V2 EM M4</td><td>0.58</td><td>0.30</td></... | <table><tr><td>Comparison</td><td>Pearson’s Correlation coefficient</td><td>R-squared value</td></tr><tr><td>NBME (raw) version V1 EM M4</td><td>0.51</td><td>0.26</td></tr><tr><td>NBME (scaled) version V1 EM M4</td><td>0.42</td><td>0.18</td></tr></table> | <table><tr><td>Comparison</td><td>Pearson’s Correlation coefficient</td><td>R-squared value</td></tr><tr><td>NBME (raw) version V2 EM M4</td><td>0.58</td><td>0.30</td></tr><tr><td>NBME (scaled) version V2 EM M4</td><td>0.41</td><td>0.13</td></tr></table> |
4d48182074db0a66f8eddfe4bf1ea5bfca78d69c00a6974e007a1501a61f0cff.png | complex | <table><tr><td>Temperature (°C)</td><td>SR<sup>a </sup>(%)</td><td colspan="4">Yields of hydrolyzed sugars from</td><td>Total yield (%)</td><td>CrI<sup>b </sup>(%)</td></tr><tr><td></td><td></td><td colspan="2">Soluble fraction</td><td colspan="2">Residue</td><td></td><td></td></tr><tr><td></td><td></td><td>Glucos... | <table><tr><td>Temperature (°C)</td><td>SRa (%)</td><td colspan="2">Yields of hydrolyzed sugars from</td></tr><tr><td></td><td></td><td colspan="2">Soluble fraction</td></tr><tr><td></td><td></td><td>Glucose (%)</td><td>Xylose (%)</td></tr><tr><td>120</td><td>99.1</td><td>0.1</td><td>0.0</td></tr><tr><td>140</td><td>96... | <table><tr><td colspan="2">Yields of hydrolyzed sugars from</td><td>Total yield (%)</td><td>CrIb (%)</td></tr><tr><td colspan="2">Residue</td><td></td><td></td></tr><tr><td>Glucose (%)</td><td>Xylose (%)</td><td></td><td></td></tr><tr><td>3.8</td><td>0.0</td><td>3.1</td><td>60.4</td></tr><tr><td>5.9</td><td>5.3</td><td... |
30ee6332cc360f9091b3384185d9e8f7660b1f3c7efd78cae934ab0252b5cb4b.png | simple | <table><tr><td>Cluster name</td><td>Voxels</td><td>p</td><td><i>Z</i>-MAX</td><td>MNI coordinates (mm)</td><td>Anatomical regions</td></tr><tr><td>rIPS</td><td>2163</td><td>1.19E-06</td><td>3.82</td><td>32, − 72, 40</td><td>Right lateral occipital cortex</td></tr><tr><td>lIPS</td><td>1149</td><td>0.0011</td><td>3... | <table><tr><td>Cluster name</td><td>Voxels</td><td>p</td><td>Z-MAX</td><td>MNI coordinates (mm)</td><td>Anatomical regions</td></tr><tr><td>rIPS</td><td>2163</td><td>1.19E-06</td><td>3.82</td><td>32, − 72, 40</td><td>Right lateral occipital cortex</td></tr></table> | <table><tr><td>lIPS</td><td>1149</td><td>0.0011</td><td>3.53</td><td>-33, − 42, 41</td><td>Left superior parietal lobule, left angular gyrus</td></tr><tr><td>rFEF</td><td>1117</td><td>0.00141</td><td>3.52</td><td>30, − 2, 62</td><td>Right superior frontal gyrus</td></tr><tr><td>rSPL</td><td>735</td><td>0.031</td><td>3.... |
5d915c89671cfab7329c6dea16b9b396c76c51aeef6aa00bdc938ab509582820.png | simple | <table><tr><td></td><td>Total</td><td>Participators</td><td>Non-participators</td><td><i>P</i></td></tr><tr><td></td><td>(n = 172)</td><td>(n = 114)</td><td>(n = 58)</td><td></td></tr><tr><td>Medical care</td><td></td><td></td><td></td><td></td></tr><tr><td> Advice by a physician to undergo screening</td><td>65 (40.4)<... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Medical care</td></tr><tr><td>Advice by a physician to undergo screening</td></tr><tr><td>Score for perceived accessibility of colonoscopy centres (1 to 5)</td></tr><tr><td>Family</td></tr><tr><td>Index patient sex: female</td></tr><tr><td>Index patient age at time of ... | <table><tr><td>Total</td><td>Participators</td><td>Non-participators</td><td>P</td></tr><tr><td>(n = 172)</td><td>(n = 114)</td><td>(n = 58)</td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>65 (40.4)</td><td>58 (53.7)</td><td>7 (13.2)</td><td>< 10-4</td></tr><tr><td>3.8 (1.2)</td><td>4.0 (1.2)</td... |
f365de98815b04d439165a1c21114c6e6f54e6f7c6589f14cae79f2cdab9e22f.png | simple | <table><tr><td>Exercise</td><td>CTR</td><td>SR</td><td>WR</td></tr><tr><td>AS</td><td>9.6/10.6</td><td>10.2/7.0*</td><td>7.07/10.1*</td></tr><tr><td>OHS</td><td>16.2/14.6</td><td>9.8/7.8*</td><td>8.7/7.8</td></tr><tr><td>FS</td><td>11.9/9.6</td><td>9.2/14.8*</td><td>5.0/11.5*</td></tr><tr><td>DL</td><td>8.2/7.7</td><td... | <table><tr><td>Exercise</td><td>CTR</td><td>SR</td><td>WR</td></tr><tr><td>AS</td><td>9.6/10.6</td><td>10.2/7.0*</td><td>7.07/10.1*</td></tr></table> | <table><tr><td>OHS</td><td>16.2/14.6</td><td>9.8/7.8*</td><td>8.7/7.8</td></tr><tr><td>FS</td><td>11.9/9.6</td><td>9.2/14.8*</td><td>5.0/11.5*</td></tr><tr><td>DL</td><td>8.2/7.7</td><td>4.8/7.9*</td><td>4.1/7.8*</td></tr></table> |
51199896c6f8ae53eade2ac025a8e580fcb51a84cecd1f2f75b168334fb86d2c.png | simple | <table><tr><td>Treatment or procedure</td><td>Number of patients</td><td>Proportion of patients</td></tr><tr><td>Laboratory examinations such as blood samples, urine stick test and cultivation</td><td>96</td><td>67.6%</td></tr><tr><td>Electrocardiography</td><td>64</td><td>45.1%</td></tr><tr><td>Diagnostic radiology pr... | <table><tr><td>Treatment or procedure</td><td>Number of patients</td><td>Proportion of patients</td></tr><tr><td>Laboratory examinations such as blood samples, urine stick test and cultivation</td><td>96</td><td>67.6%</td></tr></table> | <table><tr><td>Treatment or procedure</td><td>Number of patients</td><td>Proportion of patients</td></tr><tr><td>Electrocardiography</td><td>64</td><td>45.1%</td></tr><tr><td>Diagnostic radiology procedures</td><td>42</td><td>29.6%</td></tr><tr><td>Medicine administered per orally, suppository or as an ointment</td><td... |
1642069ad4b9d1a65f36d9d6287caa1cfdc23eb33895f694626b85e88db414bc.png | complex | <table><tr><td rowspan="2">Surgeon pair</td><td colspan="3">Kappa values</td></tr><tr><td>Trial 1</td><td>Trial 2</td><td>Mean</td></tr><tr><td colspan="4">Right hip</td></tr><tr><td>1–2</td><td>0.48 (M)</td><td>0.48 (M)</td><td>0.48 (M)</td></tr><tr><td>1–3</td><td>0.74 (G)</td><td>0.63 (G)</td><td>0.69 (G... | <table><tr><td rowspan="2">Surgeon pair</td><td colspan="3">Kappa values</td></tr><tr><td>Trial 1</td><td>Trial 2</td><td>Mean</td></tr><tr><td colspan="4">Right hip</td></tr></table> | <table><tr><td rowspan="2">Surgeon pair</td><td colspan="3">Kappa values</td></tr><tr><td>Trial 1</td><td>Trial 2</td><td>Mean</td></tr><tr><td>1–2</td><td>0.48 (M)</td><td>0.48 (M)</td><td>0.48 (M)</td></tr><tr><td>1–3</td><td>0.74 (G)</td><td>0.63 (G)</td><td>0.69 (G)</td></tr><tr><td>1–4</td><td>0.84 (V)</td><td>0.8... |
c5daef64bfdca522ccf409403dee55c11776cb27e37878dba0a8703fed6ddb38.png | simple | <table><tr><td>Strains</td><td></td><td>Functional Predictions</td><td>Total SNP(%)</td><td>Genes Affected(%)</td></tr><tr><td>C57BL/6J vs. DBA/2J</td><td>PolyPhen</td><td>Deleterious</td><td>1,755 (19.4%)</td><td>954 (26.1%)</td></tr><tr><td></td><td></td><td>Benign</td><td>6,757 (74.5%)</td><td>2,343 (64%)</td></tr><... | <table><tr><td>Strains</td></tr><tr><td>C57BL/6J vs. DBA/2J</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>C57BL/6J vs. 129S1/SvImJ</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></t... | <table><tr><td></td><td>Functional Predictions</td><td>Total SNP(%)</td><td>Genes Affected(%)</td></tr><tr><td>PolyPhen</td><td>Deleterious</td><td>1,755 (19.4%)</td><td>954 (26.1%)</td></tr><tr><td></td><td>Benign</td><td>6,757 (74.5%)</td><td>2,343 (64%)</td></tr><tr><td></td><td>Unknown</td><td>567 (6.3%)</td><td>36... |
29b9812584002397a9049d8e1ebbd6fdc6137a5133267d6f482dfa0e95f12d45.png | simple | <table><tr><td>Step</td><td></td></tr><tr><td>1.</td><td>X μL <sup>125</sup>I is added to wobbling reaction vial</td></tr><tr><td>2.</td><td>250 μL phosphate buffer (0.5 M, pH 7.4) is added</td></tr><tr><td>3.</td><td>50 μL BoNT-A/ phosphate buffer (=50 μg BoNT-A) is added<sup>a</sup></td></tr><tr><... | <table><tr><td>Step</td><td></td></tr><tr><td>1.</td><td>X μL 125I is added to wobbling reaction vial</td></tr><tr><td>2.</td><td>250 μL phosphate buffer (0.5 M, pH 7.4) is added</td></tr><tr><td>3.</td><td>50 μL BoNT-A/ phosphate buffer (=50 μg BoNT-A) is addeda</td></tr><tr><td>4.</td><td>115-X μL phosphate buffer (0... | <table><tr><td>Step</td><td></td></tr><tr><td>8.</td><td>At t = 4.30 min, 10 μL BSA (50 mg/mL) is addedb</td></tr><tr><td>9.</td><td>At t = 5.30 min, samples are taken for ITLC for determination of the labelling efficiency</td></tr><tr><td>10.</td><td>At t = 10 min, 360 μL reaction mixture is transferred to a syringe c... |
5d214135b3daa7d70c358296b5b9a79f30c91eca99fe1f70cb9abc2b96051de5.png | simple | <table><tr><td>Patient</td><td>Sex/Age of onset</td><td>Mutations (exon)</td><td>Phenotype</td><td>Kayser-Freicher rings</td><td>Serum ceruloplasmin</td><td>Serum free copper</td><td>24 h urinary copper</td><td>AST</td><td>ALT</td><td>PT</td></tr><tr><td>Normal</td><td></td><td></td><td></td><td>–</td><td>20̵... | <table><tr><td>Patient</td><td>Sex/Age of onset</td><td>Mutations (exon)</td><td>Phenotype</td><td>Kayser-Freicher rings</td><td>Serum ceruloplasmin</td><td>Serum free copper</td><td>24 h urinary copper</td><td>AST</td><td>ALT</td><td>PT</td></tr></table> | <table><tr><td>Normal</td><td></td><td></td><td></td><td>–</td><td>20–35 mg/dL</td><td><15 μg/dL</td><td><60–100 μg</td><td><40 IU/L</td><td><40 IU/L</td><td>>70%</td></tr><tr><td>Patient 1</td><td>Male/8</td><td>p.Phe1026Tyr (exon 14),c.2866-2A > G(intron 12)</td><td>Hepatic, Neurologic</td><td>+</td><td>0.0032 mg/dL<... |
09c2f63c5185b59242cb2db46b7b1c6e52519e81718f3f21ba1e2e90ceb839dc.png | complex | <table><tr><td colspan="2">Variables</td><td>Number</td><td>Percent</td></tr><tr><td rowspan="3">Gravida (number of pregnancies)</td><td>1</td><td>78</td><td>24.4</td></tr><tr><td>2–4</td><td>183</td><td>57.2</td></tr><tr><td>> = 5</td><td>59</td><td>18.4</td></tr><tr><td rowspan="4">Parity (number of deliveri... | <table><tr><td colspan="2">Variables</td><td>Number</td><td>Percent</td></tr><tr><td rowspan="3">Gravida (number of pregnancies)</td><td>1</td><td>78</td><td>24.4</td></tr><tr><td>2–4</td><td>183</td><td>57.2</td></tr><tr><td>> = 5</td><td>59</td><td>18.4</td></tr><tr><td rowspan="4">Parity (number of deliveries)</td><... | <table><tr><td rowspan="2">Birth order</td><td>2–4</td><td>116</td><td>36.3</td></tr><tr><td>> = 5</td><td>25</td><td>7.8</td></tr><tr><td rowspan="2">Pregnancy Trimester during interview</td><td>Second trimester</td><td>115</td><td>35.9</td></tr><tr><td>Third trimester</td><td>205</td><td>64.1</td></tr><tr><td rowspan... |
7d3e87c45d8031fdd9366c4c2f705acd38e422c62c53e86007967bfe119aacdf.png | complex | <table><tr><td>System</td><td>Complications</td></tr><tr><td>Neurologic</td><td>Cord compression syndrome</td></tr><tr><td> </td><td>Intracranial hypertension/hydrocephalus</td></tr><tr><td>Thoracic</td><td>Superior vena cava syndrome</td></tr><tr><td rowspan="4"> </td><td>Pericardial effusion/cardiac tamponade</td></t... | <table><tr><td>System</td></tr><tr><td>Neurologic</td></tr><tr><td></td></tr><tr><td>Thoracic</td></tr><tr><td rowspan="4"></td></tr><tr></tr><tr></tr><tr></tr><tr><td>Abdominal</td></tr><tr><td rowspan="4"></td></tr><tr></tr><tr></tr><tr></tr></table> | <table><tr><td>Complications</td></tr><tr><td>Cord compression syndrome</td></tr><tr><td>Intracranial hypertension/hydrocephalus</td></tr><tr><td>Superior vena cava syndrome</td></tr><tr><td>Pericardial effusion/cardiac tamponade</td></tr><tr><td>Pleural effusion</td></tr><tr><td>Pulmonary thromboembolism</td></tr><tr>... |
86b030a3541d9efd13d91b86e07e0d99dee1c3eef8f7ec508d059e6b6179b2cb.png | simple | <table><tr><td>Category</td><td>No. (%)</td></tr><tr><td>Infection</td><td>331 (59.1)</td></tr><tr><td> Respiratory tract</td><td>166 (51.2)</td></tr><tr><td> Urinary tract</td><td>99 (30.6)</td></tr><tr><td> Intra-abdominal</td><td>39 (12.1)</td></tr><tr><td> Skin and soft tissue</td><td>18 (3.2)</td></tr><tr><td> Pri... | <table><tr><td>Category</td><td>No. (%)</td></tr><tr><td>Infection</td><td>331 (59.1)</td></tr><tr><td>Respiratory tract</td><td>166 (51.2)</td></tr><tr><td>Urinary tract</td><td>99 (30.6)</td></tr><tr><td>Intra-abdominal</td><td>39 (12.1)</td></tr></table> | <table><tr><td>Skin and soft tissue</td><td>18 (3.2)</td></tr><tr><td>Primary bacteremia/fungemia</td><td>10 (3.1)</td></tr><tr><td>Central nervous system</td><td>2 (0.6)</td></tr><tr><td>Bone & joint</td><td>2 (0.6)</td></tr><tr><td>Other</td><td>2 (0.6)</td></tr><tr><td>Non-infection</td><td>179 (32.0)</td></tr><tr><... |
b12e3659d31b4e062d68431bf407ec7ded6b179e10c9971369a16aa3589d5d02.png | complex | <table><tr><td>Parameters</td><td>Mutants</td><td colspan="2">Salt concentrations</td></tr><tr><td></td><td></td><td><i>R</i></td><td><i>P</i>-value</td></tr><tr><td>Early PCD</td><td>Col-0</td><td>0.869<sup>**</sup></td><td>0.00</td></tr><tr><td></td><td><i>ein2-5</i></td><td>0.972<sup>**</sup></td><td>0.00</td></tr><... | <table><tr><td>Parameters</td><td>Mutants</td><td colspan="2">Salt concentrations</td></tr><tr><td></td><td></td><td>R</td><td>P-value</td></tr><tr><td>Early PCD</td><td>Col-0</td><td>0.869**</td><td>0.00</td></tr><tr><td></td><td></td><td></td><td>0.00</td></tr></table> | <table><tr><td>Parameters</td><td>Mutants</td><td colspan="2">Salt concentrations</td></tr><tr><td></td><td></td><td>R</td><td>P-value</td></tr><tr><td></td><td>ein2-5</td><td>0.972**</td><td></td></tr><tr><td></td><td>ein3-1</td><td>0.913**</td><td>0.00</td></tr><tr><td></td><td>ctr1-1</td><td>0.766*</td><td>0.02</td>... |
c39c0cd84f64a8f04d154e5f777ea0e35541d3b348a8021b982eccfe37089356.png | simple | <table><tr><td></td><td>Audio</td><td>Visual</td><td>Sim. dual</td><td>Seq. dual</td></tr><tr><td>Mean accuracy rate ± s.e.m. (%)</td><td>95.2 ± 1.6</td><td>97.3 ± 1.2</td><td>89.9 ± 1.9</td><td>94.9 ± 1.1</td></tr></table> | <table><tr><td></td><td>A</td><td>Visu</td><td>Sim</td><td>S</td></tr></table> | <table><tr><td></td><td>udio</td><td>al</td><td>. dual</td><td>eq. dual</td></tr><tr><td>Mean accuracy rate ± s.e.m. (%)</td><td>95.2 ± 1.6</td><td>97.3 ± 1.2</td><td>89.9 ± 1.9</td><td>94.9 ± 1.1</td></tr></table> |
74dbfc704bfc4f518cc8c7334ae2118d80ca86ef78fc4aeac21ce9f5d4da872f.png | simple | <table><tr><td> Histomorphometry<sup>1</sup></td><td>Sham control</td><td>Vehicle control</td><td>CAPT</td><td>P 31.25</td><td>P 62.5</td><td>P125</td><td>LOSA</td></tr><tr><td>Degenerative regions</td><td>1.73 ± 1.60</td><td>78.92 ± 8.56*</td><td>56.76 ± 10.36<sup>∗,#</sup></td><td>54.79 ± 10... | <table><tr><td>Histomorphometry1</td><td>Sham control</td><td>Vehicle control</td><td>CAPT</td><td>P 31.25</td><td>P 62.5</td><td>P125</td><td>LOSA</td></tr></table> | <table><tr><td>Degenerative regions</td><td>1.73 ± 1.60</td><td>78.92 ± 8.56*</td><td>56.76 ± 10.36∗,#</td><td>54.79 ± 10.93∗,#</td><td>40.50 ± 12.92∗,#</td><td>33.73 ± 5.77∗,#</td><td>63.80 ± 10.24∗,##</td></tr></table> |
607cb97e27ee908ccc809cf18832c1193c1b036c9d6b9ef3719e621f06b4a31b.png | simple | <table><tr><td>Dataset</td><td>No.of Training(class1/class2)</td><td>No.of Testing(class1/class2)</td></tr><tr><td>Leukaemia</td><td>50(32 ALL/18 AML)</td><td>22 (15 ALL/7 AML)</td></tr><tr><td>Prostate</td><td>71(35 ALL/36 AML)</td><td>31(15 ALL/16 AML)</td></tr><tr><td>Colon</td><td>42(14 Normal/28 Tumor)</td><td>20(... | <table><tr><td>Dataset</td><td>No.of Training(class1/class2)</td><td>No.of Testing(class1/class2)</td></tr><tr><td>Leukaemia</td><td>50(32 ALL/18 AML)</td><td>22 (15 ALL/7 AML)</td></tr><tr><td>Prostate</td><td>71(35 ALL/36 AML)</td><td>31(15 ALL/16 AML)</td></tr></table> | <table><tr><td>Colon</td><td>42(14 Normal/28 Tumor)</td><td>20(8 Normal/12 Tumor)</td></tr><tr><td>DLBCL</td><td>60(45 DLBCL/15FL)</td><td>17(13 DLBCL/4 FL)</td></tr></table> |
857d3f7499598f19d4c356693d5647e94e963590e6b54e2259cb76b3415c861e.png | complex | <table><tr><td colspan="5">Disinfectants</td><td colspan="2">Neutralizing agents</td></tr><tr><td>Classification</td><td>Active ingredients</td><td>Recommended concentration</td><td>Recommended contact time</td><td>Optimal application</td><td>Active ingredients</td><td>Concentration</td></tr><tr><td>Aldehydes</td><td>G... | <table><tr><td colspan="5">Disinfectants</td><td colspan="2">Neutralizing agents</td></tr><tr><td>Classification</td><td>Active ingredients</td><td>Recommended concentration</td><td>Recommended contact time</td><td>Optimal application</td><td>Active ingredients</td><td>Concentration</td></tr><tr><td>Aldehyd</td><td>Glu... | <table><tr><td>es</td><td>hyde</td><td>%</td><td></td><td>uipment, goods</td><td>e</td><td></td></tr><tr><td rowspan="2">Halogens</td><td>Sodium hypochlorite</td><td>2 g/L</td><td>20 min</td><td>Biological material, smooth surface</td><td>Sodium thiosulfate</td><td>0.2%</td></tr><tr><td>Trichloroisocyanuric acid</td><t... |
d647b963beb27b59c5751c325e854542677cf91f9313a7d617524890eac44e53.png | simple | <table><tr><td>Code</td><td>Features</td><td>Preparation room use</td></tr><tr><td>A</td><td>No Intubation</td><td>NO</td></tr><tr><td>B</td><td>General Anesthesia and Intubation</td><td>NO</td></tr><tr><td>C</td><td>B + One Procedure</td><td>NO / YES</td></tr><tr><td>D</td><td>B + More Than One Procedure</td><td>NO / ... | <table><tr><td>Code</td></tr><tr><td>A</td></tr><tr><td>B</td></tr><tr><td>C</td></tr><tr><td>D</td></tr></table> | <table><tr><td>Features</td><td>Preparation room use</td></tr><tr><td>No Intubation</td><td>NO</td></tr><tr><td>General Anesthesia and Intubation</td><td>NO</td></tr><tr><td>B + One Procedure</td><td>NO / YES</td></tr><tr><td>B + More Than One Procedure</td><td>NO / YES</td></tr></table> |
a4e2d993cab077d3d4427402a4d2354c169e147a1f63155fa4ae9d78c9f0a264.png | complex | <table><tr><td>Categorical variables</td><td>N* (n = 199)</td><td>%</td><td>Crude</td><td>p value**</td></tr><tr><td>Continuous variables<sup>#</sup></td><td> </td><td>Mean(SD)</td><td>OR</td><td> </td></tr><tr><td><i>Home ownership</i></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Own home (fully owned or ... | <table><tr><td>Categorical variables</td><td>N* (n = 199)</td><td>%</td><td>Crude</td><td>p value**</td></tr><tr><td>Continuous variables#</td><td></td><td>Mean(SD)</td><td>OR</td><td></td></tr><tr><td>Home ownership</td><td></td><td></td><td></td><td></td></tr><tr><td>Own home (fully owned or mortgaged)</td><td>162</t... | <table><tr><td>Categorical variables</td><td>N* (n = 199)</td><td>%</td><td>Crude</td><td>p value**</td></tr><tr><td>Continuous variables#</td><td></td><td>Mean(SD)</td><td>OR</td><td></td></tr><tr><td>Wealth index</td><td></td><td></td><td></td><td></td></tr><tr><td>Richer half</td><td>104</td><td>1.9%</td><td>1</td><... |
054dfe2ac2a865730ab709081de50d8607ff37ee44f31b2b32065f47f953d75d.png | simple | <table><tr><td>Country</td><td>Maize</td><td>Other major crops</td></tr><tr><td>Bangladesh</td><td>No</td><td>Eggplant</td></tr><tr><td>India</td><td>No</td><td>Cotton, soybean</td></tr><tr><td>Iran</td><td>No</td><td>Rice</td></tr><tr><td>Myanmar</td><td>No</td><td>Cotton</td></tr><tr><td>Pakistan</td><td>No</td><td>C... | <table><tr><td>Country</td><td>Maize</td><td>Other major crops</td></tr><tr><td>Bangladesh</td><td>No</td><td>Eggplant</td></tr><tr><td>India</td><td>No</td><td>Cotton, soybean</td></tr><tr><td>Iran</td><td>No</td><td>Rice</td></tr><tr><td>Myanmar</td><td>No</td><td>Cotton</td></tr><tr><td>Pakistan</td><td>No</td><td>C... | <table><tr><td>Country</td><td>Maize</td><td>Other major crops</td></tr><tr><td>South Korea</td><td>Yes</td><td>Alfalfa, canola, cotton, potato, soybean</td></tr><tr><td>Thailand</td><td>Yes</td><td>Soybean</td></tr><tr><td>Turkey</td><td>Yes</td><td>Soybean</td></tr><tr><td>Vietnam</td><td>Yes</td><td>None</td></tr></... |
74d4235da1bdf4e3c8304df0c02139f38e9076496659d3a36cae1ad75d0f5aa9.png | complex | <table><tr><td>Strain</td><td colspan="4">24 hours</td><td colspan="4">48 hours</td></tr><tr><td></td><td>Product(mg/L)</td><td colspan="3">Intermediates(mg/L)</td><td>Product(mg/L)</td><td colspan="3">Intermediates(mg/L)</td></tr><tr><td></td><td>caffeic acid</td><td>tyrosine</td><td><i>p</i>-coumaric acid</td><td><i>... | <table><tr><td>Strain</td><td colspan="4">24 hours</td><td colspan="3">48 hours</td></tr><tr><td></td><td>Product(mg/L)</td><td colspan="3">Intermediates(mg/L)</td><td>Product(mg/L)</td><td colspan="2">Intermediates(mg/L)</td></tr><tr><td></td><td>caffeic acid</td><td>tyrosine</td><td>p-coumaric acid</td><td>L-dopa</td... | <table><tr><td>48 hours</td></tr><tr><td>Intermediates(mg/L)</td></tr><tr><td>L-dopa</td></tr><tr><td>7.4 ± 0.2</td></tr><tr><td>14.2 ± 1.7</td></tr><tr><td>-</td></tr><tr><td>-</td></tr><tr><td>75.3 ± 13.6</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.